<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38248274</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3425</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>Brain sciences</Title><ISOAbbreviation>Brain Sci</ISOAbbreviation></Journal><ArticleTitle>Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">59</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/brainsci14010059</ELocationID><Abstract><AbstractText>Central nervous system (CNS) pathologies are a public health concern, with viral infections one of their principal causes. These viruses are known as neurotropic pathogens, characterized by their ability to infiltrate the CNS and thus interact with various cell populations, inducing several diseases. The immune response elicited by neurotropic viruses in the CNS is commanded mainly by microglia, which, together with other local cells, can secrete inflammatory cytokines to fight the infection. The most relevant neurotropic viruses are adenovirus (AdV), cytomegalovirus (CMV), enterovirus (EV), Epstein-Barr Virus (EBV), herpes simplex virus type 1 (HSV-1), and herpes simplex virus type 2 (HSV-2), lymphocytic choriomeningitis virus (LCMV), and the newly discovered SARS-CoV-2. Several studies have associated a viral infection with systemic lupus erythematosus (SLE) and neuropsychiatric lupus (NPSLE) manifestations. This article will review the knowledge about viral infections, CNS pathologies, and the immune response against them. Also, it allows us to understand the relevance of the different viral proteins in developing neuronal pathologies, SLE and NPSLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Uribe</LastName><ForeName>Felipe R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Laboratorio de Inmunología Traslacional, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8370146, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González</LastName><ForeName>Valentina P I</ForeName><Initials>VPI</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Laboratorio de Inmunología Traslacional, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8370146, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalergis</LastName><ForeName>Alexis M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-7622-5263</Identifier><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 8330025, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soto</LastName><ForeName>Jorge A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Laboratorio de Inmunología Traslacional, Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8370146, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bohmwald</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6794-7544</Identifier><AffiliationInfo><Affiliation>Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma, Santiago 8910060, Chile.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NID ACE 210015 (CN09_016 / ICN 2021_045; former P09/016-F)</GrantID><Agency>Millennium Institute on Immunology and Immunotherapy</Agency><Country /></Grant><Grant><GrantID>1190830,</GrantID><Agency>Agencia Nacional de Investigación y Desarrollo</Agency><Country /></Grant><Grant><GrantID>1190864</GrantID><Agency>Agencia Nacional de Investigación y Desarrollo</Agency><Country /></Grant><Grant><GrantID>1170964</GrantID><Agency>Agencia Nacional de Investigación y Desarrollo</Agency><Country /></Grant><Grant><GrantID>1231866</GrantID><Agency>Agencia Nacional de Investigación y Desarrollo</Agency><Country /></Grant><Grant><GrantID>11221280</GrantID><Agency>Agencia Nacional de Investigación y Desarrollo</Agency><Country /></Grant><Grant><GrantID>SA77210051</GrantID><Agency>PAI</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Sci</MedlineTA><NlmUniqueID>101598646</NlmUniqueID><ISSNLinking>2076-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aseptic meningitis</Keyword><Keyword MajorTopicYN="N">central nervous system</Keyword><Keyword MajorTopicYN="N">encephalitis</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">neurotropic viruses</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38248274</ArticleId><ArticleId IdType="pmc">PMC10813552</ArticleId><ArticleId IdType="doi">10.3390/brainsci14010059</ArticleId><ArticleId IdType="pii">brainsci14010059</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang Z., Song Y., Kang J., Duan S., Li Q., Feng F., Duan J. Epidemiology of Patients with Central Nervous System Infections, Mainly Neurosurgical Patients: A Retrospective Study from 2012 to 2019 in a Teaching Hospital in China. BMC Infect. Dis. 2021;21:826. doi: 10.1186/s12879-021-06561-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06561-2</ArticleId><ArticleId IdType="pmc">PMC8369693</ArticleId><ArticleId IdType="pubmed">34404351</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes N.G.L., Boni M., Primo C.C. The Invasive Behaviour of Shape Cryptococcus Neoformans: A Possibility of Direct Access to the Central Nervous System? Mycopathologia. 1997;140:1–11. doi: 10.1023/A:1006809522931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1006809522931</ArticleId><ArticleId IdType="pubmed">9608719</ArticleId></ArticleIdList></Reference><Reference><Citation>Medana I.M., Mai N.T.H., Day N.P.J., Hien T.T., Bethell D., Phu N.H., Farrar J., White N.J., Turner G.D.H. Cellular Stress and Injury Responses in the Brains of Adult Vietnamese Patients with Fatal Plasmodium falciparum Malaria. Neuropathol. Appl. Neurobiol. 2001;27:421–433. doi: 10.1046/j.0305-1846.2001.00360.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0305-1846.2001.00360.x</ArticleId><ArticleId IdType="pubmed">11903925</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki T., Itamura S., Nishimura H., Sato Y., Tashiro M., Hashikawa T., Kurata T. Productive Infection in the Murine Central Nervous System with Avian Influenza Virus A (H5N1) after Intranasal Inoculation. Acta Neuropathol. 2004;108:485–492. doi: 10.1007/s00401-004-0909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0909-0</ArticleId><ArticleId IdType="pubmed">15480712</ArticleId></ArticleIdList></Reference><Reference><Citation>Flexner S. Contributions to the pathology of experimental virus encephalitis. J. Exp. Med. 1928;47:9–22. doi: 10.1084/jem.47.1.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.47.1.9</ArticleId><ArticleId IdType="pmc">PMC2131345</ArticleId><ArticleId IdType="pubmed">19869403</ArticleId></ArticleIdList></Reference><Reference><Citation>McGill F., Griffiths M.J., Bonnett L.J., Geretti A.M., Michael B.D., Beeching N.J., McKee D., Scarlett P., Hart I.J., Mutton K.J., et al. Incidence, Aetiology, and Sequelae of Viral Meningitis in UK Adults: A Multicentre Prospective Observational Cohort Study. Lancet Infect. Dis. 2018;18:992–1003. doi: 10.1016/S1473-3099(18)30245-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30245-7</ArticleId><ArticleId IdType="pmc">PMC6105576</ArticleId><ArticleId IdType="pubmed">30153934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Zhao S., Wang S., Zheng Y., Wang S., Chen H., Pang J., Ma J., Yang X., Chen Y. Global Magnitude of Encephalitis Burden and Its Evolving Pattern over the Past 30 Years. J. Infect. 2022;84:777–787. doi: 10.1016/j.jinf.2022.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.04.026</ArticleId><ArticleId IdType="pubmed">35452715</ArticleId></ArticleIdList></Reference><Reference><Citation>Handley G., Pankow S., Bard J.D., Yee R., Nigo M., Hasbun R. Distinguishing Cytomegalovirus Meningoencephalitis from Other Viral Central Nervous System Infections. J. Clin. Virol. 2021;142:104936. doi: 10.1016/j.jcv.2021.104936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104936</ArticleId><ArticleId IdType="pubmed">34352616</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H., Chen D., Peng X., Wu P., Jiang L., Hu Y. Clinical Characteristics of Epstein–Barr Virus Infection in the Pediatric Nervous System. BMC Infect. Dis. 2020;20:886. doi: 10.1186/s12879-020-05623-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05623-1</ArticleId><ArticleId IdType="pmc">PMC7691062</ArticleId><ArticleId IdType="pubmed">33238935</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride M., Williman J., Best E., Walls T., Sadarangani M., Grant C.C., Martin N.G. The Epidemiology of Aseptic Meningitis in New Zealand Children from 1991 to 2020. J Paediatr. Child Health. 2022;58:1980–1989. doi: 10.1111/jpc.16131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.16131</ArticleId><ArticleId IdType="pmc">PMC9796418</ArticleId><ArticleId IdType="pubmed">35861029</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew S., Al Khatib H.A., Al Ansari K., Nader J., Nasrallah G.K., Younes N.N., Coyle P.V., Al Thani A.A., Al Maslamani M.A., Yassine H.M. Epidemiology Profile of Viral Meningitis Infections Among Patients in Qatar (2015–2018) Front. Med. 2021;8:663694. doi: 10.3389/fmed.2021.663694.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.663694</ArticleId><ArticleId IdType="pmc">PMC8241925</ArticleId><ArticleId IdType="pubmed">34222280</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Quintial R., Mayeux J.M., Kono D.H., Theofilopoulos A.N., Pollard K.M., Baccala R. Silica Exposure and Chronic Virus Infection Synergistically Promote Lupus-like Systemic Autoimmunity in Mice with Low Genetic Predisposition. Clin. Immunol. 2019;205:75–82. doi: 10.1016/j.clim.2019.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.06.003</ArticleId><ArticleId IdType="pmc">PMC6646094</ArticleId><ArticleId IdType="pubmed">31175964</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Li H., Wu C., Zhang Y. Epstein-Barr Virus and Human Herpesvirus 6 Infection in Patients with Systemic Lupus Erythematosus. Virol. J. 2023;20:29. doi: 10.1186/s12985-023-01987-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-01987-3</ArticleId><ArticleId IdType="pmc">PMC9926755</ArticleId><ArticleId IdType="pubmed">36782252</ArticleId></ArticleIdList></Reference><Reference><Citation>Pérez-Mercado A.E., Vilá-Pérez S. Cytomegalovirus as a Trigger for Systemic Lupus Erythematosus. JCR J. Clin. Rheumatol. 2010;16:335–337. doi: 10.1097/RHU.0b013e3181f4cf52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0b013e3181f4cf52</ArticleId><ArticleId IdType="pubmed">20859222</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiyad Z., Moriarty B., Creamer D., Higgins E. Generalized Pustular Psoriasis Associated with Epstein-Barr Virus. Clin. Exp. Dermatol. 2015;40:146–148. doi: 10.1111/ced.12493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ced.12493</ArticleId><ArticleId IdType="pubmed">25267463</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O.H., Honkanen H., Pakkanen O., Oikarinen S., Hankaniemi M.M., Huhtala H., Ruokoranta T., Lecouturier V., André P., Harju R., et al. Coxsackievirus B1 Is Associated With Induction of β-Cell Autoimmunity That Portends Type 1 Diabetes. Diabetes. 2014;63:446–455. doi: 10.2337/db13-0619.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-0619</ArticleId><ArticleId IdType="pubmed">23974921</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuoka S., Kusunoki N., Takamatsu R., Takahashi H., Tsuchiya K., Kawai S., Nanki T. Epstein-Barr Virus Infection and Variants of Epstein-Barr Nuclear Antigen-1 in Synovial Tissues of Rheumatoid Arthritis. PLoS ONE. 2018;13:e0208957. doi: 10.1371/journal.pone.0208957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208957</ArticleId><ArticleId IdType="pmc">PMC6289453</ArticleId><ArticleId IdType="pubmed">30533036</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothe K., Quandt D., Schubert K., Rossol M., Klingner M., Jasinski-Bergner S., Scholz R., Seliger B., Pierer M., Baerwald C., et al. Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T Cells. Arthritis Rheumatol. 2016;68:337–346. doi: 10.1002/art.39331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39331</ArticleId><ArticleId IdType="pmc">PMC5066744</ArticleId><ArticleId IdType="pubmed">26314621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanadgol N., Ramroodi N., Ahmadi G.A., Komijani M., Moghtaderi A., Bouzari M., Rezaei M., Kardi M.T., Dabiri S., Moradi M., et al. Prevalence of Cytomegalovirus Infection and Its Role in Total Immunoglobulin Pattern in Iranian Patients with Different Subtypes of Multiple Sclerosis. New Microbiol. 2011;34:263–274.</Citation><ArticleIdList><ArticleId IdType="pubmed">21811746</ArticleId></ArticleIdList></Reference><Reference><Citation>Maple P.A.C., Tanasescu R., Gran B., Constantinescu C.S. A Different Response to Cytomegalovirus (CMV) and Epstein–Barr Virus (EBV) Infection in UK People with Multiple Sclerosis (PwMS) Compared to Controls. J. Infect. 2020;80:320–325. doi: 10.1016/j.jinf.2019.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2019.10.017</ArticleId><ArticleId IdType="pubmed">31678173</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandman-Goddard G., Berkun Y., Barzilai O., Boaz M., Ram M., Anaya J., Shoenfeld Y. Neuropsychiatric Lupus and Infectious Triggers. Lupus. 2008;17:380–384. doi: 10.1177/0961203308090017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308090017</ArticleId><ArticleId IdType="pubmed">18490412</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad A., Coles A., Gibson M.D.J. 8. False Positive Mumps Serology in a Patient with Cerebral Systemic Lupus Erythematosus. Rheumatol. Adv. Pract. 2018;2:rky033. doi: 10.1093/rap/rky033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rap/rky033</ArticleId></ArticleIdList></Reference><Reference><Citation>Turtzo L.C., Jikaria N., Cota M.R., Williford J.P., Uche V., Davis T., MacLaren J., Moses A.D., Parikh G., Castro M.A., et al. Meningeal Blood–Brain Barrier Disruption in Acute Traumatic Brain Injury. Brain Commun. 2020;2:fcaa143. doi: 10.1093/braincomms/fcaa143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa143</ArticleId><ArticleId IdType="pmc">PMC7869431</ArticleId><ArticleId IdType="pubmed">33829156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumani H., Huss A., Bachhuber F. The Cerebrospinal Fluid and Barriers—Anatomic and Physiologic Considerations. Handb. Clin. Neurol. 2018;146:21–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">29110772</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Clijsters M., Choi S., Backaert W., Claerhout M., Couvreur F., Van Breda L., Bourgeois F., Speleman K., Klein S., et al. Anatomical Barriers against SARS-CoV-2 Neuroinvasion at Vulnerable Interfaces Visualized in Deceased COVID-19 Patients. Neuron. 2022;110:3919–3935.e6. doi: 10.1016/j.neuron.2022.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.11.007</ArticleId><ArticleId IdType="pmc">PMC9647025</ArticleId><ArticleId IdType="pubmed">36446381</ArticleId></ArticleIdList></Reference><Reference><Citation>Moseman E.A., Blanchard A.C., Nayak D., McGavern D.B. T Cell Engagement of Cross-Presenting Microglia Protects the Brain from a Nasal Virus Infection. Sci. Immunol. 2020;5:eabb1817. doi: 10.1126/sciimmunol.abb1817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abb1817</ArticleId><ArticleId IdType="pmc">PMC7416530</ArticleId><ArticleId IdType="pubmed">32503876</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrauwen E.J.A., Herfst S., Leijten L.M., van Run P., Bestebroer T.M., Linster M., Bodewes R., Kreijtz J.H.C.M., Rimmelzwaan G.F., Osterhaus A.D.M.E., et al. The Multibasic Cleavage Site in H5N1 Virus Is Critical for Systemic Spread along the Olfactory and Hematogenous Routes in Ferrets. J. Virol. 2012;86:3975–3984. doi: 10.1128/JVI.06828-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06828-11</ArticleId><ArticleId IdType="pmc">PMC3302532</ArticleId><ArticleId IdType="pubmed">22278228</ArticleId></ArticleIdList></Reference><Reference><Citation>Delbue S., Franciotta D., Giannella S., Dolci M., Signorini L., Ticozzi R., D’Alessandro S., Campisciano G., Comar M., Ferrante P., et al. Human Polyomaviruses in the Cerebrospinal Fluid of Neurological Patients. Microorganisms. 2019;8:16. doi: 10.3390/microorganisms8010016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8010016</ArticleId><ArticleId IdType="pmc">PMC7022863</ArticleId><ArticleId IdType="pubmed">31861837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko A., Delbaz A., Choudhury I.N., Eindorf T., Shah M., Godfrey C., Sullivan M.J., St John J.A., Ulett G.C., Ekberg J.A.K. Streptococcus Agalactiae Infects Glial Cells and Invades the Central Nervous System via the Olfactory and Trigeminal Nerves. Front. Cell Infect. Microbiol. 2022;12:188. doi: 10.3389/fcimb.2022.793416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.793416</ArticleId><ArticleId IdType="pmc">PMC8907725</ArticleId><ArticleId IdType="pubmed">35281448</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat N.R., Fan F. Adenovirus Infection Induces Microglial Activation: Involvement of Mitogen-Activated Protein Kinase Pathways. Brain Res. 2002;948:93–101. doi: 10.1016/S0006-8993(02)02953-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(02)02953-0</ArticleId><ArticleId IdType="pubmed">12383959</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra P., Rani A., Sharma N., Mukherjee C., Jha H.C. Unraveling the Connection of Epstein–Barr Virus and Its Glycoprotein M 146–157 Peptide with Neurological Ailments. ACS Chem. Neurosci. 2023;14:2450–2460. doi: 10.1021/acschemneuro.3c00231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.3c00231</ArticleId><ArticleId IdType="pubmed">37290090</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik J.R., Acharya A., Avedissian S.N., Byrareddy S.N., Fletcher C.V., Podany A.T., Dyavar S.R. ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics. Int. J. Mol. Sci. 2023;24:8622. doi: 10.3390/ijms24108622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108622</ArticleId><ArticleId IdType="pmc">PMC10218482</ArticleId><ArticleId IdType="pubmed">37239978</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrasiabi A., Keane J.T., Ong L.T.C., Alinejad-Rokny H., Fewings N.L., Booth D.R., Parnell G.P., Swaminathan S. Genetic and Transcriptomic Analyses Support a Switch to Lytic Phase in Epstein Barr Virus Infection as an Important Driver in Developing Systemic Lupus Erythematosus. J. Autoimmun. 2022;127:102781. doi: 10.1016/j.jaut.2021.102781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102781</ArticleId><ArticleId IdType="pubmed">34952359</ArticleId></ArticleIdList></Reference><Reference><Citation>Luethy L.N., Erickson A.K., Jesudhasan P.R., Ikizler M., Dermody T.S., Pfeiffer J.K. Comparison of Three Neurotropic Viruses Reveals Differences in Viral Dissemination to the Central Nervous System. Virology. 2016;487:1–10. doi: 10.1016/j.virol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.09.019</ArticleId><ArticleId IdType="pmc">PMC4679581</ArticleId><ArticleId IdType="pubmed">26479325</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor-Godwin J.M., Ruller C.M., Bagalso N., An N., Pagarigan R.R., Harkins S., Gilbert P.E., Kiosses W.B., Gude N.A., Cornell C.T., et al. A Novel Population of Myeloid Cells Responding to Coxsackievirus Infection Assists in the Dissemination of Virus within the Neonatal CNS. J. Neurosci. 2010;30:8676–8691. doi: 10.1523/JNEUROSCI.1860-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1860-10.2010</ArticleId><ArticleId IdType="pmc">PMC2902258</ArticleId><ArticleId IdType="pubmed">20573913</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyuncu O.O., Hogue I.B., Enquist L.W. Virus Infections in the Nervous System. Cell Host Microbe. 2013;13:379–393. doi: 10.1016/j.chom.2013.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.03.010</ArticleId><ArticleId IdType="pmc">PMC3647473</ArticleId><ArticleId IdType="pubmed">23601101</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson J.K., Girvin A.M., Miller S.D. Direct Activation of Innate and Antigen-Presenting Functions of Microglia Following Infection with Theiler’s Virus. J. Virol. 2001;75:9780–9789. doi: 10.1128/JVI.75.20.9780-9789.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.20.9780-9789.2001</ArticleId><ArticleId IdType="pmc">PMC114550</ArticleId><ArticleId IdType="pubmed">11559811</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Wang X., Yang Q., Yan X., Fan Y., Zhang S., Wei Y., Huang M., Jiang L., Feng L. Collaborative Action of Microglia and Astrocytes Mediates Neutrophil Recruitment to the CNS to Defend against Escherichia Coli K1 Infection. Int. J. Mol. Sci. 2022;23:6540. doi: 10.3390/ijms23126540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23126540</ArticleId><ArticleId IdType="pmc">PMC9223767</ArticleId><ArticleId IdType="pubmed">35742984</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Nishikawaji Y., Kawakami H., Kosai K. Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy. Viruses. 2021;13:2502. doi: 10.3390/v13122502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122502</ArticleId><ArticleId IdType="pmc">PMC8706629</ArticleId><ArticleId IdType="pubmed">34960772</ArticleId></ArticleIdList></Reference><Reference><Citation>Saban S.D., Silvestry M., Nemerow G.R., Stewart P.L. Visualization of α-Helices in a 6-Ångstrom Resolution Cryoelectron Microscopy Structure of Adenovirus Allows Refinement of Capsid Protein Assignments. J. Virol. 2006;80:12049–12059. doi: 10.1128/JVI.01652-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01652-06</ArticleId><ArticleId IdType="pmc">PMC1676273</ArticleId><ArticleId IdType="pubmed">17005667</ArticleId></ArticleIdList></Reference><Reference><Citation>Davison A.J., Benkő M., Harrach B. Genetic Content and Evolution of Adenoviruses. J. Gen. Virol. 2003;84:2895–2908. doi: 10.1099/vir.0.19497-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19497-0</ArticleId><ArticleId IdType="pubmed">14573794</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.G., Wiethoff C.M., Stewart P.L., Nemerow G.R. Current topics in microbiology and immunology. Volume 343. Springer; New York, NY, USA: 2010. Adenovirus; pp. 195–224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/82_2010_16</ArticleId><ArticleId IdType="pmc">PMC3093298</ArticleId><ArticleId IdType="pubmed">20376613</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa-Calatrava M., Grave L., Puvion-Dutilleul F., Chatton B., Kedinger C. Functional Analysis of Adenovirus Protein IX Identifies Domains Involved in Capsid Stability, Transcriptional Activity, and Nuclear Reorganization. J. Virol. 2001;75:7131–7141. doi: 10.1128/JVI.75.15.7131-7141.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.15.7131-7141.2001</ArticleId><ArticleId IdType="pmc">PMC114442</ArticleId><ArticleId IdType="pubmed">11435594</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyer C.L., Besser E.S., Nemerow G.R. A Single Maturation Cleavage Site in Adenovirus Impacts Cell Entry and Capsid Assembly. J. Virol. 2016;90:521–532. doi: 10.1128/JVI.02014-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02014-15</ArticleId><ArticleId IdType="pmc">PMC4702569</ArticleId><ArticleId IdType="pubmed">26491163</ArticleId></ArticleIdList></Reference><Reference><Citation>San Martín C. Latest Insights on Adenovirus Structure and Assembly. Viruses. 2012;4:847–877. doi: 10.3390/v4050847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4050847</ArticleId><ArticleId IdType="pmc">PMC3386624</ArticleId><ArticleId IdType="pubmed">22754652</ArticleId></ArticleIdList></Reference><Reference><Citation>van Riel D., Verdijk R., Kuiken T. The Olfactory Nerve: A Shortcut for Influenza and Other Viral Diseases into the Central Nervous System. J. Pathol. 2015;235:277–287. doi: 10.1002/path.4461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4461</ArticleId><ArticleId IdType="pubmed">25294743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou J., Baker L.A., Zhou L., Klein R.S. Viral Interactions with the Blood-Brain Barrier: Old Dog, New Tricks. Tissue Barriers. 2016;4:e1142492. doi: 10.1080/21688370.2016.1142492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21688370.2016.1142492</ArticleId><ArticleId IdType="pmc">PMC4836465</ArticleId><ArticleId IdType="pubmed">27141421</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.-C., Huang S.-L., Chen S.-P., Huang Y.-L., Huang C.-G., Tsao K.-C., Lin T.-Y. Adenovirus Infection Associated with Central Nervous System Dysfunction in Children. J. Clin. Virol. 2013;57:300–304. doi: 10.1016/j.jcv.2013.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2013.03.017</ArticleId><ArticleId IdType="pubmed">23619053</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca G.J., Thillainadesan G., Yousef A.F., Ablack J.N., Mossman K.L., Torchia J., Mymryk J.S. Adenovirus Evasion of Interferon-Mediated Innate Immunity by Direct Antagonism of a Cellular Histone Posttranslational Modification. Cell Host Microbe. 2012;11:597–606. doi: 10.1016/j.chom.2012.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.05.005</ArticleId><ArticleId IdType="pubmed">22704620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn S.-Y., Hearing P. Adenovirus Sequesters Phosphorylated STAT1 at Viral Replication Centers and Inhibits STAT Dephosphorylation. J. Virol. 2011;85:7555–7562. doi: 10.1128/JVI.00513-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00513-11</ArticleId><ArticleId IdType="pmc">PMC3147932</ArticleId><ArticleId IdType="pubmed">21593149</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q., Yu D.-H., Fang C., Liu F., Ye X., Zhao Y., Qin J., Guo X.-K., Liang M., Hu F., et al. Influence of E3 Region on Conditionally Replicative Adenovirus Mediated Cytotoxicity in Hepatocellular Carcinoma Cells. Cancer Biol. Ther. 2009;8:1125–1132. doi: 10.4161/cbt.8.12.8445.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cbt.8.12.8445</ArticleId><ArticleId IdType="pubmed">19448394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sester M., Koebernick K., Owen D., Ao M., Bromberg Y., May E., Stock E., Andrews L., Groh V., Spies T., et al. Conserved Amino Acids within the Adenovirus 2 E3/19K Protein Differentially Affect Downregulation of MHC Class I and MICA/B Proteins. J. Immunol. 2010;184:255–267. doi: 10.4049/jimmunol.0902343.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902343</ArticleId><ArticleId IdType="pubmed">19949079</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme E., Van Loock M. Functional Annotation of Human Cytomegalovirus Gene Products: An Update. Front. Microbiol. 2014;5:218. doi: 10.3389/fmicb.2014.00218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2014.00218</ArticleId><ArticleId IdType="pmc">PMC4032930</ArticleId><ArticleId IdType="pubmed">24904534</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J., Cao D., Yang S., Jaijyan D.K., Liu X., Wu S., Cruz-Cosme R., Tang Q., Zhu H. Insights into the Transcriptome of Human Cytomegalovirus: A Comprehensive Review. Viruses. 2023;15:1703. doi: 10.3390/v15081703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15081703</ArticleId><ArticleId IdType="pmc">PMC10458407</ArticleId><ArticleId IdType="pubmed">37632045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki H., Kosugi I., Sakao-Suzuki M., Meguro S., Arai Y., Tsutsui Y., Iwashita T. Cytomegalovirus Initiates Infection Selectively from High-Level Β1 Integrin–Expressing Cells in the Brain. Am. J. Pathol. 2015;185:1304–1323. doi: 10.1016/j.ajpath.2015.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2015.01.032</ArticleId><ArticleId IdType="pubmed">25797647</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Savitz J. Microorganisms and Mental Health. Springer International Publishing; Cham, Switzerland: 2022. Effect of Cytomegalovirus Infection on the Central Nervous System: Implications for Psychiatric Disorders; pp. 215–241.</Citation><ArticleIdList><ArticleId IdType="pubmed">35505056</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Mohan A., Smith-Rohrberg D., Sethu M. Cytomegalovirus Polyradiculopathy: A Rare Neurological Manifestation of Acquired Immunodeficiency Syndrome. Neurol. India. 2008;56:493. doi: 10.4103/0028-3886.44826.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0028-3886.44826</ArticleId><ArticleId IdType="pubmed">19127057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosugi I., Shinmura Y., Kawasaki H., Arai Y., Li R.-Y., Baba S., Tsutsui Y. Cytomegalovirus Infection of the Central Nervous System Stem Cells from Mouse Embryo: A Model for Developmental Brain Disorders Induced by Cytomegalovirus. Lab. Investig. 2000;80:1373–1383. doi: 10.1038/labinvest.3780145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3780145</ArticleId><ArticleId IdType="pubmed">11005206</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigoleit U., Riegler S., Einsele H., Laib Sampaio K., Jahn G., Hebart H., Brossart P., Frank F., Sinzger C. Human Cytomegalovirus Induces a Direct Inhibitory Effect on Antigen Presentation by Monocyte-Derived Immature Dendritic Cells. Br. J. Haematol. 2002;119:189–198. doi: 10.1046/j.1365-2141.2002.03798.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2002.03798.x</ArticleId><ArticleId IdType="pubmed">12358925</ArticleId></ArticleIdList></Reference><Reference><Citation>Baasch S., Giansanti P., Kolter J., Riedl A., Forde A.J., Runge S., Zenke S., Elling R., Halenius A., Brabletz S., et al. Cytomegalovirus Subverts Macrophage Identity. Cell. 2021;184:3774–3793.e25. doi: 10.1016/j.cell.2021.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.05.009</ArticleId><ArticleId IdType="pubmed">34115982</ArticleId></ArticleIdList></Reference><Reference><Citation>LoPiccolo D.M., Gold M.C., Kavanagh D.G., Wagner M., Koszinowski U.H., Hill A.B. Effective Inhibition of Kb- and Db-Restricted Antigen Presentation in Primary Macrophages by Murine Cytomegalovirus. J. Virol. 2003;77:301–308. doi: 10.1128/JVI.77.1.301-308.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.1.301-308.2003</ArticleId><ArticleId IdType="pmc">PMC140608</ArticleId><ArticleId IdType="pubmed">12477835</ArticleId></ArticleIdList></Reference><Reference><Citation>Baicus A., Baicus C. In: Neuronal Infections. Singh S.K., Ruzek D., editors. CRC Press; Boca Raton, FL, USA: 2013.</Citation></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., Wang J. The 3C Protein of Enterovirus 71 Inhibits Retinoid Acid-Inducible Gene I-Mediated Interferon Regulatory Factor 3 Activation and Type I Interferon Responses. J. Virol. 2010;84:8051–8061. doi: 10.1128/JVI.02491-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne C.B., Bozym R., Morosky S.A., Hanna S.L., Mukherjee A., Tudor M., Kim K.S., Cherry S. Comparative RNAi Screening Reveals Host Factors Involved in Enterovirus Infection of Polarized Endothelial Monolayers. Cell Host Microbe. 2011;9:70–82. doi: 10.1016/j.chom.2011.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.01.001</ArticleId><ArticleId IdType="pmc">PMC3048761</ArticleId><ArticleId IdType="pubmed">21238948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Sun J., Wang N., Sun Z., Ma Q., Li J., Zhang M., Xu J. Enterovirus A71 Capsid Protein VP1 Increases Blood–Brain Barrier Permeability and Virus Receptor Vimentin on the Brain Endothelial Cells. J. Neurovirol. 2020;26:84–94. doi: 10.1007/s13365-019-00800-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-019-00800-8</ArticleId><ArticleId IdType="pmc">PMC7040057</ArticleId><ArticleId IdType="pubmed">31512144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Z.Q., Ng Q.Y., Oo Y., Chu J.J.H., Ng S.Y., Sze S.K., Alonso S. Enterovirus-A71 Exploits Peripherin and Rac1 to Invade the Central Nervous System. EMBO Rep. 2021;22:e51777. doi: 10.15252/embr.202051777.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202051777</ArticleId><ArticleId IdType="pmc">PMC8183415</ArticleId><ArticleId IdType="pubmed">33871166</ArticleId></ArticleIdList></Reference><Reference><Citation>Piralla A., Pellegrinelli L., Giardina F., Galli C., Binda S., Pariani E., Baldanti F. Contribution of Enteroviruses to Acute Central Nervous System or Systemic Infections in Northern Italy (2015–2017): Is It Time to Establish a National Laboratory-Based Surveillance System? BioMed Res. Int. 2020;2020:9393264. doi: 10.1155/2020/9393264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/9393264</ArticleId><ArticleId IdType="pmc">PMC7352123</ArticleId><ArticleId IdType="pubmed">32685546</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai R.-H., Chow Y.-H., Chung N.-H., Chen T.-C., Shie F.-S., Juang J.-L. Neurotropic EV71 Causes Encephalitis by Engaging Intracellular TLR9 to Elicit Neurotoxic IL12-P40-INOS Signaling. Cell Death Dis. 2022;13:328. doi: 10.1038/s41419-022-04771-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04771-3</ArticleId><ArticleId IdType="pmc">PMC8995170</ArticleId><ArticleId IdType="pubmed">35399111</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ceano-Vivas M., García M.L., Velázquez A., Martín del Valle F., Menasalvas A., Cilla A., Epalza C., Romero M.P., Cabrerizo M., Calvo C. Neurodevelopmental Outcomes of Infants Younger Than 90 Days Old Following Enterovirus and Parechovirus Infections of the Central Nervous System. Front. Pediatr. 2021;9:719119. doi: 10.3389/fped.2021.719119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.719119</ArticleId><ArticleId IdType="pmc">PMC8505960</ArticleId><ArticleId IdType="pubmed">34650940</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.-Y., Huang L.-M., Gau S.S.-F., Wu Y.-Y., Hsia S.-H., Fan T.-Y., Lin K.-L., Huang Y.-C., Lu C.-Y., Lin T.-Y. Neurodevelopment and Cognition in Children after Enterovirus 71 Infection. N. Engl. J. Med. 2007;356:1226–1234. doi: 10.1056/NEJMoa065954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng J.-J., Lin C.-H., Lin M.-C. Long-Term Outcomes of Pediatric Enterovirus Infection in Taiwan: A Population-Based Cohort Study. Front. Pediatr. 2020;8:285. doi: 10.3389/fped.2020.00285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.00285</ArticleId><ArticleId IdType="pmc">PMC7303813</ArticleId><ArticleId IdType="pubmed">32596191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Lei X., Xiao X., Yang C., Lu W., Huang Z., Leng Q., Jin Q., He B., Meng G., et al. Reciprocal Regulation between Enterovirus 71 and the NLRP3 Inflammasome. Cell Rep. 2015;12:42–48. doi: 10.1016/j.celrep.2015.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.05.047</ArticleId><ArticleId IdType="pubmed">26119741</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z., Liu L., Lei X., Zhou Z., He B., Wang J. 3C Protease of Enterovirus D68 Inhibits Cellular Defense Mediated by Interferon Regulatory Factor 7. J. Virol. 2016;90:1613–1621. doi: 10.1128/JVI.02395-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02395-15</ArticleId><ArticleId IdType="pmc">PMC4719596</ArticleId><ArticleId IdType="pubmed">26608321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J., Pang Z., Zhou Z., Li X., Liu S., Cheng J., Liu P., Tan W., Wang Z., Wang T. Enterovirus D68 Protease 2A pro Targets TRAF3 To Subvert Host Innate Immune Responses. J. Virol. 2021;95:10–1128. doi: 10.1128/JVI.01856-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01856-20</ArticleId><ArticleId IdType="pmc">PMC7925118</ArticleId><ArticleId IdType="pubmed">33148796</ArticleId></ArticleIdList></Reference><Reference><Citation>Young L.S. Encyclopedia of Virology. Elsevier; Amsterdam, The Netherlands: 2008. Epstein–Barr Virus: General Features; pp. 148–157.</Citation></Reference><Reference><Citation>Indari O., Chandramohanadas R., Jha H.C. Epstein–Barr Virus Infection Modulates Blood–Brain Barrier Cells and Its Co-Infection with Plasmodium falciparum Induces RBC Adhesion. Pathog. Dis. 2021;79:ftaa080. doi: 10.1093/femspd/ftaa080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femspd/ftaa080</ArticleId><ArticleId IdType="pubmed">33355336</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams M.V., Cox B., Lafuse W.P., Ariza M.E. Epstein-Barr Virus DUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Clin. Ther. 2019;41:848–863. doi: 10.1016/j.clinthera.2019.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.04.009</ArticleId><ArticleId IdType="pmc">PMC6525645</ArticleId><ArticleId IdType="pubmed">31040055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace L.A., English S.W., Fugate J.E., Tosh P.K. Acute Epstein-Barr Virus Infection Presenting as Guillain-Barre Syndrome. IDCases. 2021;25:e01196. doi: 10.1016/j.idcr.2021.e01196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2021.e01196</ArticleId><ArticleId IdType="pmc">PMC8217676</ArticleId><ArticleId IdType="pubmed">34189041</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhi P., Sharma J.P., Gautam R., Indra R.M., Rafli A. Extensive Longitudinal Transverse Myelitis Associated with CSF Epstein-Barr Virus Infection: A Case Report. Child. Neurol. Open. 2021;8:2329048X2110499. doi: 10.1177/2329048X211049958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2329048X211049958</ArticleId><ArticleId IdType="pmc">PMC8532220</ArticleId><ArticleId IdType="pubmed">34692894</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari D., Singh V.K., Baral B., Pathak D.K., Jayabalan J., Kumar R., Tapryal S., Jha H.C. Indication of Neurodegenerative Cascade Initiation by Amyloid-like Aggregate-Forming EBV Proteins and Peptide in Alzheimer’s Disease. ACS Chem. Neurosci. 2021;12:3957–3967. doi: 10.1021/acschemneuro.1c00584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00584</ArticleId><ArticleId IdType="pubmed">34609141</ArticleId></ArticleIdList></Reference><Reference><Citation>Woulfe J.M., Gray M.T., Gray D.A., Munoz D.G., Middeldorp J.M. Hypothesis: A Role for EBV-Induced Molecular Mimicry in Parkinson’s Disease. Park. Relat. Disord. 2014;20:685–694. doi: 10.1016/j.parkreldis.2014.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2014.02.031</ArticleId><ArticleId IdType="pubmed">24726430</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiu S.P.T., Zerbe C., Vanderwall D., Huttlin E.L., Weekes M.P., Gewurz B.E. An Epstein-Barr Virus Protein Interaction Map Reveals NLRP3 Inflammasome Evasion via MAVS UFMylation. Mol. Cell. 2023;83:2367–2386.e15. doi: 10.1016/j.molcel.2023.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2023.05.018</ArticleId><ArticleId IdType="pmc">PMC10372749</ArticleId><ArticleId IdType="pubmed">37311461</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Sadaoka T., Krogmann T., Cohen J.I. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation. J. Virol. 2020;94:10–1128. doi: 10.1128/JVI.00258-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00258-20</ArticleId><ArticleId IdType="pmc">PMC7269453</ArticleId><ArticleId IdType="pubmed">32213613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Deng Y., Guo Y., Xu Z., Li Y., Ou X., Xie L., Lu M., Zhong J., Li B., et al. Epstein-Barr Virus Early Protein BFRF1 Suppresses IFN-β Activity by Inhibiting the Activation of IRF3. Front. Immunol. 2020;11:513383. doi: 10.3389/fimmu.2020.513383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.513383</ArticleId><ArticleId IdType="pmc">PMC7774019</ArticleId><ArticleId IdType="pubmed">33391252</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Liu D., Hutt-Fletcher L., Morgan A., Masucci M.G., Levitsky V. Epstein-Barr Virus Inhibits the Development of Dendritic Cells by Promoting Apoptosis of Their Monocyte Precursors in the Presence of Granulocyte Macrophage–Colony-Stimulating Factor and Interleukin-4. Blood. 2002;99:3725–3734. doi: 10.1182/blood.V99.10.3725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V99.10.3725</ArticleId><ArticleId IdType="pubmed">11986229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrozek-Gorska P., Buschle A., Pich D., Schwarzmayr T., Fechtner R., Scialdone A., Hammerschmidt W. Epstein–Barr Virus Reprograms Human B Lymphocytes Immediately in the Prelatent Phase of Infection. Proc. Natl. Acad. Sci. USA. 2019;116:16046–16055. doi: 10.1073/pnas.1901314116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901314116</ArticleId><ArticleId IdType="pmc">PMC6690029</ArticleId><ArticleId IdType="pubmed">31341086</ArticleId></ArticleIdList></Reference><Reference><Citation>Megyola C., Ye J., Bhaduri-McIntosh S. Identification of a Sub-Population of B Cells That Proliferates after Infection with Epstein-Barr Virus. Virol. J. 2011;8:84. doi: 10.1186/1743-422X-8-84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-84</ArticleId><ArticleId IdType="pmc">PMC3056814</ArticleId><ArticleId IdType="pubmed">21352549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma N., Lu J., Pei Y., Robertson E.S. Transcriptome Reprogramming of Epstein-Barr Virus Infected Epithelial and B Cells Reveals Distinct Host-Virus Interaction Profiles. Cell Death Dis. 2022;13:894. doi: 10.1038/s41419-022-05327-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-05327-1</ArticleId><ArticleId IdType="pmc">PMC9588026</ArticleId><ArticleId IdType="pubmed">36272970</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman I.R., Boehmer P.E. Replication of Herpes Simplex Virus DNA. J. Biol. Chem. 1999;274:28059–28062. doi: 10.1074/jbc.274.40.28059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.40.28059</ArticleId><ArticleId IdType="pubmed">10497152</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubinski J.M., Lazear H.M., Awasthi S., Wang F., Friedman H.M. The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo. J. Virol. 2011;85:3239–3249. doi: 10.1128/JVI.02509-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02509-10</ArticleId><ArticleId IdType="pmc">PMC3067879</ArticleId><ArticleId IdType="pubmed">21228231</ArticleId></ArticleIdList></Reference><Reference><Citation>Komala Sari T., Gianopulos K.A., Nicola A.V. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization. J. Virol. 2020;94:10–1128. doi: 10.1128/JVI.01852-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01852-19</ArticleId><ArticleId IdType="pmc">PMC7022361</ArticleId><ArticleId IdType="pubmed">31826995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Morales R., Andreu S., López-Guerrero J.A. The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System. Int. J. Mol. Sci. 2020;21:5026. doi: 10.3390/ijms21145026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145026</ArticleId><ArticleId IdType="pmc">PMC7404202</ArticleId><ArticleId IdType="pubmed">32708697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp S.J., Ranaivo H.R., Wilcox D.R., Karaba A.H., Wainwright M.S., Muller W.J. Herpes Simplex Virus Serotype and Entry Receptor Availability Alter CNS Disease in a Mouse Model of Neonatal HSV. Pediatr. Res. 2014;76:528–534. doi: 10.1038/pr.2014.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2014.135</ArticleId><ArticleId IdType="pmc">PMC4233006</ArticleId><ArticleId IdType="pubmed">25198371</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q., Liu H., Huang C., Wang R., Luo M., Lu W. Herpes Simplex Virus 1-Induced Blood-Brain Barrier Damage Involves Apoptosis Associated With GM130-Mediated Golgi Stress. Front. Mol. Neurosci. 2020;13:2. doi: 10.3389/fnmol.2020.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00002</ArticleId><ArticleId IdType="pmc">PMC6992570</ArticleId><ArticleId IdType="pubmed">32038167</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Qiu K., He Q., Lei Q., Lu W. Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis. J. Neuroimmune Pharmacol. 2019;14:157–172. doi: 10.1007/s11481-018-9821-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-018-9821-6</ArticleId><ArticleId IdType="pubmed">30456443</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozenberg F. Herpes Simplex Virus and Central Nervous System Infections: Encephalitis, Meningitis, Myelitis. Virologie. 2020;24:283–294. doi: 10.1684/vir.2020.0862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/vir.2020.0862</ArticleId><ArticleId IdType="pubmed">33111702</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy M.J., Fani L., Ikram M.K., Ghanbari M., Ikram M.A. Herpes Simplex Virus 1 and the Risk of Dementia: A Population-Based Study. Sci. Rep. 2021;11:8691. doi: 10.1038/s41598-021-87963-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-87963-9</ArticleId><ArticleId IdType="pmc">PMC8062537</ArticleId><ArticleId IdType="pubmed">33888766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., He B. Recognition of Herpes Simplex Viruses: Toll-Like Receptors and Beyond. J. Mol. Biol. 2014;426:1133–1147. doi: 10.1016/j.jmb.2013.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.11.012</ArticleId><ArticleId IdType="pmc">PMC3943799</ArticleId><ArticleId IdType="pubmed">24262390</ArticleId></ArticleIdList></Reference><Reference><Citation>Finberg R.W., Knipe D.M., Kurt-Jones E.A. Herpes Simplex Virus and Toll-Like Receptors. Viral Immunol. 2005;18:457–465. doi: 10.1089/vim.2005.18.457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2005.18.457</ArticleId><ArticleId IdType="pubmed">16212524</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanidou M., Ramos I., Mas Casullo V., Trépanier J.B., Rosenbaum S., Fernandez-Sesma A., Herold B.C. Herpes Simplex Virus 2 (HSV-2) Prevents Dendritic Cell Maturation, Induces Apoptosis, and Triggers Release of Proinflammatory Cytokines: Potential Links to HSV-HIV Synergy. J. Virol. 2013;87:1443–1453. doi: 10.1128/JVI.01302-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01302-12</ArticleId><ArticleId IdType="pmc">PMC3554174</ArticleId><ArticleId IdType="pubmed">23152529</ArticleId></ArticleIdList></Reference><Reference><Citation>Smiley J.R. Herpes Simplex Virus Virion Host Shutoff Protein: Immune Evasion Mediated by a Viral RNase? J. Virol. 2004;78:1063–1068. doi: 10.1128/JVI.78.3.1063-1068.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.3.1063-1068.2004</ArticleId><ArticleId IdType="pmc">PMC321390</ArticleId><ArticleId IdType="pubmed">14722261</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers-Lalic D., Rijsewijk F.A.M., Verschuren S.B.E., van Gaans-van den Brink J.A.M., Neisig A., Ressing M.E., Neefjes J., Wiertz E.J.H.J. The UL41-Encoded Virion Host Shutoff (Vhs) Protein and Vhs-Independent Mechanisms Are Responsible for down-Regulation of MHC Class I Molecules by Bovine Herpesvirus 1. J. Gen. Virol. 2001;82:2071–2081. doi: 10.1099/0022-1317-82-9-2071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-82-9-2071</ArticleId><ArticleId IdType="pubmed">11514716</ArticleId></ArticleIdList></Reference><Reference><Citation>Tigges M.A., Leng S., Johnson D.C., Burke R.L. Human Herpes Simplex Virus (HSV)-Specific CD8+ CTL Clones Recognize HSV-2-Infected Fibroblasts after Treatment with IFN-Gamma or When Virion Host Shutoff Functions Are Disabled. J. Immunol. 1996;156:3901–3910. doi: 10.4049/jimmunol.156.10.3901.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.156.10.3901</ArticleId><ArticleId IdType="pubmed">8621929</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyanagi N., Kawaguchi Y. Evasion of the Cell-Mediated Immune Response by Alphaherpesviruses. Viruses. 2020;12:1354. doi: 10.3390/v12121354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12121354</ArticleId><ArticleId IdType="pmc">PMC7761393</ArticleId><ArticleId IdType="pubmed">33256093</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchmeier M.J., de la Torre J.C., Peters C.J. In: Fields Virology. Knipe D.M., Howley P.M., editors. Williams &amp; Wilkins; Philadelphia, PA, USA: 2013.</Citation></Reference><Reference><Citation>Kang S.S., McGavern D.B. Lymphocytic Choriomeningitis Infection of the Central Nervous System. Front. Biosci. 2008;4529:4529. doi: 10.2741/3021.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3021</ArticleId><ArticleId IdType="pmc">PMC5279998</ArticleId><ArticleId IdType="pubmed">18508527</ArticleId></ArticleIdList></Reference><Reference><Citation>Spindler K.R., Hsu T.-H. Viral Disruption of the Blood–Brain Barrier. Trends Microbiol. 2012;20:282–290. doi: 10.1016/j.tim.2012.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2012.03.009</ArticleId><ArticleId IdType="pmc">PMC3367119</ArticleId><ArticleId IdType="pubmed">22564250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.V., Kang S.S., Dustin M.L., McGavern D.B. Myelomonocytic Cell Recruitment Causes Fatal CNS Vascular Injury during Acute Viral Meningitis. Nature. 2009;457:191–195. doi: 10.1038/nature07591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07591</ArticleId><ArticleId IdType="pmc">PMC2702264</ArticleId><ArticleId IdType="pubmed">19011611</ArticleId></ArticleIdList></Reference><Reference><Citation>Matullo C.M., O’Regan K.J., Hensley H., Curtis M., Rall G.F. Lymphocytic Choriomeningitis Virus-Induced Mortality in Mice Is Triggered by Edema and Brain Herniation. J. Virol. 2010;84:312–320. doi: 10.1128/JVI.00727-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00727-09</ArticleId><ArticleId IdType="pmc">PMC2798401</ArticleId><ArticleId IdType="pubmed">19828618</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton L.L., Mets M.B., Beauchamp C.L. Lymphocytic Choriomeningitis Virus: Emerging Fetal Teratogen. Am. J. Obs. Gynecol. 2002;187:1715–1716. doi: 10.1067/mob.2002.126297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mob.2002.126297</ArticleId><ArticleId IdType="pubmed">12501090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma K., Singhapakdi K., Maertens P. Echoencephalography of Encephalopathy Due to Congenital Lymphocytic Choriomeningitis Virus. J. Neuroimaging. 2022;32:412–419. doi: 10.1111/jon.12989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12989</ArticleId><ArticleId IdType="pubmed">35297514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright R., Johnson D., Neumann M., Ksiazek T.G., Rollin P., Keech R.V., Bonthius D.J., Hitchon P., Grose C.F., Bell W.E., et al. Congenital Lymphocytic Choriomeningitis Virus Syndrome: A Disease That Mimics Congenital Toxoplasmosis or Cytomegalovirus Infection. Pediatrics. 1997;100:e9. doi: 10.1542/peds.100.1.e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.100.1.e9</ArticleId><ArticleId IdType="pubmed">9200383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pythoud C., Rothenberger S., Martínez-Sobrido L., de la Torre J.C., Kunz S. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS. J. Virol. 2015;89:6240–6250. doi: 10.1128/JVI.00610-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00610-15</ArticleId><ArticleId IdType="pmc">PMC4474305</ArticleId><ArticleId IdType="pubmed">25833049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pythoud C., Rodrigo W.W.S.I., Pasqual G., Rothenberger S., Martínez-Sobrido L., de la Torre J.C., Kunz S. Arenavirus Nucleoprotein Targets Interferon Regulatory Factor-Activating Kinase IKKε. J. Virol. 2012;86:7728–7738. doi: 10.1128/JVI.00187-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00187-12</ArticleId><ArticleId IdType="pmc">PMC3421673</ArticleId><ArticleId IdType="pubmed">22532683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-NCoV and Naming It SARS-CoV-2. Nat. Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0695-z</ArticleId><ArticleId IdType="pmc">PMC7095448</ArticleId><ArticleId IdType="pubmed">32123347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellett P.E., Mitra S., Holland T.C. Handbook of Clinical Neurology. Academic Press; Cambridge, MA, USA: 2014. Basics of Virology; pp. 45–66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152233</ArticleId><ArticleId IdType="pubmed">25015480</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Zhou Z., Xiao X., Tian Z., Dong X., Wang C., Li L., Ren L., Lei X., Xiang Z., et al. SARS-CoV-2 Nsp12 Attenuates Type I Interferon Production by Inhibiting IRF3 Nuclear Translocation. Cell Mol. Immunol. 2021;18:945–953. doi: 10.1038/s41423-020-00619-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00619-y</ArticleId><ArticleId IdType="pmc">PMC7907794</ArticleId><ArticleId IdType="pubmed">33637958</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad N., Laurent-Rolle M., Ahmed W.S., Hsu J.C.-C., Mitchell S.M., Pawlak J., Sengupta D., Biswas K.H., Cresswell P. SARS-CoV-2 Accessory Proteins ORF7a and ORF3a Use Distinct Mechanisms to down-Regulate MHC-I Surface Expression. Proc. Natl. Acad. Sci. USA. 2023;120:e2208525120. doi: 10.1073/pnas.2208525120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2208525120</ArticleId><ArticleId IdType="pmc">PMC9910621</ArticleId><ArticleId IdType="pubmed">36574644</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Hou P., Ma W., Wang X., Wang H., Yu Z., Chang H., Wang T., Jin S., Wang X., et al. SARS-CoV-2 ORF10 Suppresses the Antiviral Innate Immune Response by Degrading MAVS through Mitophagy. Cell Mol. Immunol. 2022;19:67–78. doi: 10.1038/s41423-021-00807-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00807-4</ArticleId><ArticleId IdType="pmc">PMC8628139</ArticleId><ArticleId IdType="pubmed">34845370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., et al. SARS-CoV-2 Crosses the Blood–Brain Barrier Accompanied with Basement Membrane Disruption without Tight Junctions Alteration. Signal Transduct. Target. Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., Bullock T.A., McGary H.M., Khan J.A., Razmpour R., Hale J.F., Galie P.A., Potula R., et al. The SARS-CoV-2 Spike Protein Alters Barrier Function in 2D Static and 3D Microfluidic in-Vitro Models of the Human Blood–Brain Barrier. Neurobiol. Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitale-Cross L., Szalayova I., Scoggins A., Palkovits M., Mezey E. SARS-CoV-2 Entry Sites Are Present in All Structural Elements of the Human Glossopharyngeal and Vagal Nerves: Clinical Implications. EBioMedicine. 2022;78:103981. doi: 10.1016/j.ebiom.2022.103981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103981</ArticleId><ArticleId IdType="pmc">PMC8978584</ArticleId><ArticleId IdType="pubmed">35390636</ArticleId></ArticleIdList></Reference><Reference><Citation>Green R., Mayilsamy K., McGill A.R., Martinez T.E., Chandran B., Blair L.J., Bickford P.C., Mohapatra S.S., Mohapatra S. SARS-CoV-2 Infection Increases the Gene Expression Profile for Alzheimer’s Disease Risk. Mol. Ther. Methods Clin. Dev. 2022;27:217–229. doi: 10.1016/j.omtm.2022.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2022.09.007</ArticleId><ArticleId IdType="pmc">PMC9508696</ArticleId><ArticleId IdType="pubmed">36187720</ArticleId></ArticleIdList></Reference><Reference><Citation>Vossler D.G. Does SARS-CoV-2 Cause Seizures and Epilepsy in COVID-19 via Inflammation or by Direct Infection? Epilepsy Curr. 2023;23:153–155. doi: 10.1177/15357597231160601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15357597231160601</ArticleId><ArticleId IdType="pmc">PMC10273813</ArticleId><ArticleId IdType="pubmed">37334425</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P.-P., He Z.-C., Yao X.-H., Tang R., Ma J., Luo T., Zhu C., Li T.-R., Liu X., Zhang D., et al. COVID-19-Associated Monocytic Encephalitis (CAME): Histological and Proteomic Evidence from Autopsy. Signal Transduct. Target. Ther. 2023;8:24. doi: 10.1038/s41392-022-01291-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01291-6</ArticleId><ArticleId IdType="pmc">PMC9816522</ArticleId><ArticleId IdType="pubmed">36609561</ArticleId></ArticleIdList></Reference><Reference><Citation>Abenza Abildúa M.J., Atienza S., Carvalho Monteiro G., Erro Aguirre M.E., Imaz Aguayo L., Freire Álvarez E., García-Azorín D., Gil-Olarte Montesinos I., Lara Lezama L.B., Navarro Pérez M.P., et al. Encephalopathy and Encephalitis during Acute SARS-CoV-2 Infection. Spanish Society of Neurology’s COVID-19 Registry. Neurología. 2021;36:127–134. doi: 10.1016/j.nrl.2020.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.11.013</ArticleId><ArticleId IdType="pmc">PMC7833484</ArticleId><ArticleId IdType="pubmed">33549369</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Deng J., Han L., Zhuang M.-W., Xu Y., Zhang J., Nan M.-L., Xiao Y., Zhan P., Liu X., et al. SARS-CoV-2 NSP5 and N Protein Counteract the RIG-I Signaling Pathway by Suppressing the Formation of Stress Granules. Signal Transduct. Target. Ther. 2022;7:22. doi: 10.1038/s41392-022-00878-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00878-3</ArticleId><ArticleId IdType="pmc">PMC8785035</ArticleId><ArticleId IdType="pubmed">35075101</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Pan J., Tao J., Guo D. SARS-CoV Nucleocapsid Protein Antagonizes IFN-β Response by Targeting Initial Step of IFN-β Induction Pathway, and Its C-Terminal Region Is Critical for the Antagonism. Virus Genes. 2011;42:37–45. doi: 10.1007/s11262-010-0544-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-010-0544-x</ArticleId><ArticleId IdType="pmc">PMC7088804</ArticleId><ArticleId IdType="pubmed">20976535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Li Z., Guo J., Xu S., Zhou J., Chen Q., Tong X., Wang D., Peng G., Fang L., et al. SARS-CoV-2 Nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog. J. Virol. 2022;96:e00037-22. doi: 10.1128/jvi.00037-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00037-22</ArticleId><ArticleId IdType="pmc">PMC9044939</ArticleId><ArticleId IdType="pubmed">35389264</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Muñoz A.D., Kosik I., Holly J., Yewdell J.W. Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity. Sci. Adv. 2022;8:eabp9770. doi: 10.1126/sciadv.abp9770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abp9770</ArticleId><ArticleId IdType="pmc">PMC9348789</ArticleId><ArticleId IdType="pubmed">35921414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch J., Kajon A. Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention. Semin. Respir. Crit. Care Med. 2016;37:586–602. doi: 10.1055/s-0036-1584923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0036-1584923</ArticleId><ArticleId IdType="pmc">PMC7171713</ArticleId><ArticleId IdType="pubmed">27486739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.-F., Tan C.-B., Yao Z.-X., Jiang L., Hong S.-Q. Adenovirus Infection-Associated Central Nervous System Disease in Children. Pediatr. Infect. Dis. J. 2021;40:205–208. doi: 10.1097/INF.0000000000003000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003000</ArticleId><ArticleId IdType="pubmed">33201064</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz K.L., Richardson S.E., MacGregor D., Mahant S., Raghuram K., Bitnun A. Adenovirus-Associated Central Nervous System Disease in Children. J. Pediatr. 2019;205:130–137. doi: 10.1016/j.jpeds.2018.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2018.09.036</ArticleId><ArticleId IdType="pubmed">30413311</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada M., Nakamura K., Yoshii M., Kaku Y., Narita M. Brain Lesions Induced by Experimental Intranasal Infection of Japanese Encephalitis Virus in Piglets. J. Comp. Pathol. 2009;141:156–162. doi: 10.1016/j.jcpa.2009.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcpa.2009.04.006</ArticleId><ArticleId IdType="pubmed">19523649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg H.S., Moldawer L.L., Sehgal P.B., Redington M., Kilian P.L., Chanock R.M., Prince G.A. A Mouse Model for Investigating the Molecular Pathogenesis of Adenovirus Pneumonia. Proc. Natl. Acad. Sci. USA. 1991;88:1651–1655. doi: 10.1073/pnas.88.5.1651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.5.1651</ArticleId><ArticleId IdType="pmc">PMC51082</ArticleId><ArticleId IdType="pubmed">1848005</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlin C.R. New Insights to Adenovirus-Directed Innate Immunity in Respiratory Epithelial Cells. Microorganisms. 2019;7:216. doi: 10.3390/microorganisms7080216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms7080216</ArticleId><ArticleId IdType="pmc">PMC6723309</ArticleId><ArticleId IdType="pubmed">31349602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotha P.L.N., Sharma P., Kolawole A.O., Yan R., Alghamri M.S., Brockman T.L., Gomez-Cambronero J., Excoffon K.J.D.A. Adenovirus Entry From the Apical Surface of Polarized Epithelia Is Facilitated by the Host Innate Immune Response. PLoS Pathog. 2015;11:e1004696. doi: 10.1371/journal.ppat.1004696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004696</ArticleId><ArticleId IdType="pmc">PMC4358923</ArticleId><ArticleId IdType="pubmed">25768646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zemke N.R., Berk A.J. The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling. Cell Host Microbe. 2017;22:789–800.e5. doi: 10.1016/j.chom.2017.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.11.008</ArticleId><ArticleId IdType="pmc">PMC5736016</ArticleId><ArticleId IdType="pubmed">29241042</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunis J., Farrell H.E., Bruce K., Lawler C., Wyer O., Davis-Poynter N., Brizić I., Jonjić S., Adler B., Stevenson P.G. Murine Cytomegalovirus Glycoprotein O Promotes Epithelial Cell Infection In Vivo. J. Virol. 2019;93:e01378-18. doi: 10.1128/JVI.01378-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01378-18</ArticleId><ArticleId IdType="pmc">PMC6340042</ArticleId><ArticleId IdType="pubmed">30404805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopper M., Compton T. Coiled-Coil Domains in Glycoproteins B and H Are Involved in Human Cytomegalovirus Membrane Fusion. J. Virol. 2004;78:8333–8341. doi: 10.1128/JVI.78.15.8333-8341.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.8333-8341.2004</ArticleId><ArticleId IdType="pmc">PMC446119</ArticleId><ArticleId IdType="pubmed">15254205</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosman D., Müllberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N.J. ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor. Immunity. 2001;14:123–133. doi: 10.1016/S1074-7613(01)00095-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(01)00095-4</ArticleId><ArticleId IdType="pubmed">11239445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross S.A., Pati P., Jensen T.L., Goll J.B., Gelber C.E., Singh A., McNeal M., Boppana S.B., Bernstein D.I. Cytomegalovirus Genetic Diversity Following Primary Infection. J. Infect. Dis. 2020;221:715–720. doi: 10.1093/infdis/jiz507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz507</ArticleId><ArticleId IdType="pmc">PMC7026889</ArticleId><ArticleId IdType="pubmed">31593588</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn W., Chou C., Li H., Hai R., Patterson D., Stolc V., Zhu H., Liu F. Functional Profiling of a Human Cytomegalovirus Genome. Proc. Natl. Acad. Sci. USA. 2003;100:14223–14228. doi: 10.1073/pnas.2334032100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2334032100</ArticleId><ArticleId IdType="pmc">PMC283573</ArticleId><ArticleId IdType="pubmed">14623981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuhair M., Smit G.S.A., Wallis G., Jabbar F., Smith C., Devleesschauwer B., Griffiths P. Estimation of the Worldwide Seroprevalence of Cytomegalovirus: A Systematic Review and Meta-analysis. Rev. Med. Virol. 2019;29:e2034. doi: 10.1002/rmv.2034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2034</ArticleId><ArticleId IdType="pubmed">30706584</ArticleId></ArticleIdList></Reference><Reference><Citation>Anduze-Faris B.M., Fillet A.-M., Gozlan J., Lancar R., Boukli N., Gasnault J., Caumes E., Livartowsky J., Matheron S., Leport C., et al. Induction and Maintenance Therapy of Cytomegalovirus Central Nervous System Infection in HIV-Infected Patients. AIDS. 2000;14:517–524. doi: 10.1097/00002030-200003310-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200003310-00007</ArticleId><ArticleId IdType="pubmed">10780714</ArticleId></ArticleIdList></Reference><Reference><Citation>Krstanović F., Britt W.J., Jonjić S., Brizić I. Cytomegalovirus Infection and Inflammation in Developing Brain. Viruses. 2021;13:1078. doi: 10.3390/v13061078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061078</ArticleId><ArticleId IdType="pmc">PMC8227981</ArticleId><ArticleId IdType="pubmed">34200083</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavuljica I., Kveštak D., Csaba Huszthy P., Kosmac K., Britt W.J., Jonjić S. Immunobiology of Congenital Cytomegalovirus Infection of the Central Nervous System—The Murine Cytomegalovirus Model. Cell Mol. Immunol. 2015;12:180–191. doi: 10.1038/cmi.2014.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2014.51</ArticleId><ArticleId IdType="pmc">PMC4654296</ArticleId><ArticleId IdType="pubmed">25042632</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme K.W., Singh J., Perry S.T., Compton T. Human Cytomegalovirus Elicits a Coordinated Cellular Antiviral Response via Envelope Glycoprotein B. J. Virol. 2004;78:1202–1211. doi: 10.1128/JVI.78.3.1202-1211.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.3.1202-1211.2004</ArticleId><ArticleId IdType="pmc">PMC321386</ArticleId><ArticleId IdType="pubmed">14722275</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurochko A.D., Hwang E.S., Rasmussen L., Keay S., Pereira L., Huang E.S. The Human Cytomegalovirus UL55 (GB) and UL75 (GH) Glycoprotein Ligands Initiate the Rapid Activation of Sp1 and NF-KappaB during Infection. J. Virol. 1997;71:5051–5059. doi: 10.1128/jvi.71.7.5051-5059.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.7.5051-5059.1997</ArticleId><ArticleId IdType="pmc">PMC191738</ArticleId><ArticleId IdType="pubmed">9188570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashley C., Abendroth A., McSharry B., Slobedman B. Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection Is Dependent on IRF3 Expression. Viruses. 2019;11:246. doi: 10.3390/v11030246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11030246</ArticleId><ArticleId IdType="pmc">PMC6466086</ArticleId><ArticleId IdType="pubmed">30871003</ArticleId></ArticleIdList></Reference><Reference><Citation>Billstrom Schroeder M., Worthen G.S. Viral Regulation of RANTES Expression during Human Cytomegalovirus Infection of Endothelial Cells. J. Virol. 2001;75:3383–3390. doi: 10.1128/JVI.75.7.3383-3390.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.7.3383-3390.2001</ArticleId><ArticleId IdType="pmc">PMC114131</ArticleId><ArticleId IdType="pubmed">11238864</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne E.P., Wing B., Coleman D., Shenk T. Altered Cellular MRNA Levels in Human Cytomegalovirus-Infected Fibroblasts: Viral Block to the Accumulation of Antiviral MRNAs. J. Virol. 2001;75:12319–12330. doi: 10.1128/JVI.75.24.12319-12330.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.24.12319-12330.2001</ArticleId><ArticleId IdType="pmc">PMC116128</ArticleId><ArticleId IdType="pubmed">11711622</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmen K.A., Singh J., Luukkonen B.G.M., Lopper M., Bittner A., Miller N.E., Jackson M.R., Compton T., Früh K. Global Modulation of Cellular Transcription by Human Cytomegalovirus Is Initiated by Viral Glycoprotein B. Proc. Natl. Acad. Sci. USA. 2001;98:7140–7145. doi: 10.1073/pnas.121177598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.121177598</ArticleId><ArticleId IdType="pmc">PMC34636</ArticleId><ArticleId IdType="pubmed">11390970</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxim C-J Cheeran S.H.S. Cytomegalovirus Induces Cytokine and Chemokine Production Differentially in Microglia and Astrocytes: Antiviral Implications. J. Neurovirol. 2001;7:135–147. doi: 10.1080/13550280152058799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280152058799</ArticleId><ArticleId IdType="pubmed">11517386</ArticleId></ArticleIdList></Reference><Reference><Citation>Füzik T., Moravcová J., Kalynych S., Plevka P. Structure of Human Enterovirus 70 and Its Inhibition by Capsid-Binding Compounds. J. Virol. 2022;96:e00604-22. doi: 10.1128/jvi.00604-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00604-22</ArticleId><ArticleId IdType="pmc">PMC9472761</ArticleId><ArticleId IdType="pubmed">35939401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.-M., Wu C.-C., Wu S.-E., Lin Y.-H., Wang L.-T., Chang C.-R., Huang P.-N., Shih S.-R., Kuo R.-L. The RNA-Dependent RNA Polymerase of Enterovirus A71 Associates with Ribosomal Proteins and Positively Regulates Protein Translation. RNA Biol. 2020;17:608–622. doi: 10.1080/15476286.2020.1722448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1722448</ArticleId><ArticleId IdType="pmc">PMC7237135</ArticleId><ArticleId IdType="pubmed">32009553</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X., Lei X., Zhang Z., Ma Y., Qi J., Wu C., Xiao Y., Li L., He B., Wang J. Enterovirus 3A Facilitates Viral Replication by Promoting Phosphatidylinositol 4-Kinase IIIβ–ACBD3 Interaction. J. Virol. 2017;91:10–1128. doi: 10.1128/JVI.00791-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00791-17</ArticleId><ArticleId IdType="pmc">PMC5599760</ArticleId><ArticleId IdType="pubmed">28701404</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser L.J., Langereis M.A., Rabouw H.H., Wahedi M., Muntjewerff E.M., de Groot R.J., van Kuppeveld F.J.M. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon. J. Virol. 2019;93:e00222-19. doi: 10.1128/JVI.00222-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00222-19</ArticleId><ArticleId IdType="pmc">PMC6498061</ArticleId><ArticleId IdType="pubmed">30867299</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer L., Moreni G., Wolthers K.C., Pajkrt D. World-Wide Prevalence and Genotype Distribution of Enteroviruses. Viruses. 2021;13:434. doi: 10.3390/v13030434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030434</ArticleId><ArticleId IdType="pmc">PMC7999254</ArticleId><ArticleId IdType="pubmed">33800518</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B.-S., Lee H.-C., Lee K.-M., Gong Y.-N., Shih S.-R. Enterovirus and Encephalitis. Front. Microbiol. 2020;11:261. doi: 10.3389/fmicb.2020.00261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00261</ArticleId><ArticleId IdType="pmc">PMC7044131</ArticleId><ArticleId IdType="pubmed">32153545</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng M., Guo S., Fan S., Zeng X., Zhang Y., Liao Y., Wang J., Zhao T., Wang L., Che Y., et al. The Preferential Infection of Astrocytes by Enterovirus 71 Plays a Key Role in the Viral Neurogenic Pathogenesis. Front. Cell Infect. Microbiol. 2016;6:192. doi: 10.3389/fcimb.2016.00192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2016.00192</ArticleId><ArticleId IdType="pmc">PMC5174126</ArticleId><ArticleId IdType="pubmed">28066727</ArticleId></ArticleIdList></Reference><Reference><Citation>Poelaert K.C.K., van Kleef R.G.D.M., Liu M., van Vliet A., Lyoo H., Gerber L.-S., Narimatsu Y., Büll C., Clausen H., de Vries E., et al. Enterovirus D-68 Infection of Primary Rat Cortical Neurons: Entry, Replication, and Functional Consequences. mBio. 2023;14:e00245-23. doi: 10.1128/mbio.00245-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00245-23</ArticleId><ArticleId IdType="pmc">PMC10127580</ArticleId><ArticleId IdType="pubmed">36877033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye N., Gong X., Pang L., Gao W., Zhang Y., Li X., Liu N., Li D., Jin Y., Duan Z. Cytokine Responses and Correlations Thereof with Clinical Profiles in Children with Enterovirus 71 Infections. BMC Infect. Dis. 2015;15:225. doi: 10.1186/s12879-015-0965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0965-1</ArticleId><ArticleId IdType="pmc">PMC4461975</ArticleId><ArticleId IdType="pubmed">26058678</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong X., Zhou J., Zhu W., Liu N., Li J., Li L., Jin Y., Duan Z. Excessive Proinflammatory Cytokine and Chemokine Responses of Human Monocyte-Derived Macrophages to Enterovirus 71 Infection. BMC Infect. Dis. 2012;12:224. doi: 10.1186/1471-2334-12-224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-224</ArticleId><ArticleId IdType="pmc">PMC3519709</ArticleId><ArticleId IdType="pubmed">22994237</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C., Li J., Ou Y., Chen W., Liao S., Raung S., Hsiao A., Chen C. Enterovirus 71 Infection Caused Neuronal Cell Death and Cytokine Expression in Cultured Rat Neural Cells. IUBMB Life. 2015;67:789–800. doi: 10.1002/iub.1434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1434</ArticleId><ArticleId IdType="pubmed">26399559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto A., Yamashita Y., Kanda T., Murata T., Tsurumi T. Epstein-Barr Virus Genome Packaging Factors Accumulate in BMRF1-Cores within Viral Replication Compartments. PLoS ONE. 2019;14:e0222519. doi: 10.1371/journal.pone.0222519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0222519</ArticleId><ArticleId IdType="pmc">PMC6743757</ArticleId><ArticleId IdType="pubmed">31518362</ArticleId></ArticleIdList></Reference><Reference><Citation>Henson B.W., Perkins E.M., Cothran J.E., Desai P. Self-Assembly of Epstein-Barr Virus Capsids. J. Virol. 2009;83:3877–3890. doi: 10.1128/JVI.01733-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01733-08</ArticleId><ArticleId IdType="pmc">PMC2663254</ArticleId><ArticleId IdType="pubmed">19158247</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J., Currin A., Griffin B.D., Shannon-Lowe C., Thomas W.A., Ressing M.E., Wiertz E.J.H.J., Rowe M. The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation. PLoS Pathog. 2009;5:e1000255. doi: 10.1371/journal.ppat.1000255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000255</ArticleId><ArticleId IdType="pmc">PMC2603334</ArticleId><ArticleId IdType="pubmed">19119421</ArticleId></ArticleIdList></Reference><Reference><Citation>Walston J.J., Hayman I.R., Gore M., Ferguson M., Temple R.M., Liao J., Alam S., Meyers C., Tugizov S.M., Hutt-Fletcher L., et al. The Epstein-Barr Virus Glycoprotein BDLF2 Is Essential for Efficient Viral Spread in Stratified Epithelium. J. Virol. 2023;97:e01528-22. doi: 10.1128/jvi.01528-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01528-22</ArticleId><ArticleId IdType="pmc">PMC9972961</ArticleId><ArticleId IdType="pubmed">36688650</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Zhang X., Jardetzky T.S., Longnecker R. The Epstein-Barr Virus (EBV) Glycoprotein B Cytoplasmic C-Terminal Tail Domain Regulates the Energy Requirement for EBV-Induced Membrane Fusion. J. Virol. 2014;88:11686–11695. doi: 10.1128/JVI.01349-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01349-14</ArticleId><ArticleId IdType="pmc">PMC4178708</ArticleId><ArticleId IdType="pubmed">25100836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathiyamoorthy K., Hu Y.X., Möhl B.S., Chen J., Longnecker R., Jardetzky T.S. Structural Basis for Epstein–Barr Virus Host Cell Tropism Mediated by Gp42 and GHgL Entry Glycoproteins. Nat. Commun. 2016;7:13557. doi: 10.1038/ncomms13557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13557</ArticleId><ArticleId IdType="pmc">PMC5155155</ArticleId><ArticleId IdType="pubmed">27929061</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T., Sakaida K., Yoshida M., Al Masud H.M.A., Sato Y., Goshima F., Kimura H., Murata T. The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for Its Proper Localization and Efficient Virus Production. Front. Microbiol. 2017;8:125. doi: 10.3389/fmicb.2017.00125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.00125</ArticleId><ArticleId IdType="pmc">PMC5281634</ArticleId><ArticleId IdType="pubmed">28197146</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Lu Z., Gong W., Xiao X., Feng X., Li W., Shan S., Xu D., Zhou Z. Epstein-Barr Virus Protein BKRF4 Restricts Nucleosome Assembly to Suppress Host Antiviral Responses. Proc. Natl. Acad. Sci. USA. 2022;119:e2203782119. doi: 10.1073/pnas.2203782119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2203782119</ArticleId><ArticleId IdType="pmc">PMC9477414</ArticleId><ArticleId IdType="pubmed">36067323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C.-H., Chiu Y.-F., Wang W.-H., Chen L.-W., Chang P.-J., Huang T.-Y., Lin Y.-J., Tsai W.-J., Yang C.-C. Interaction Between BGLF2 and BBLF1 Is Required for the Efficient Production of Infectious Epstein–Barr Virus Particles. Front. Microbiol. 2020;10:3021. doi: 10.3389/fmicb.2019.03021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.03021</ArticleId><ArticleId IdType="pmc">PMC6993569</ArticleId><ArticleId IdType="pubmed">32038519</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Masud H.M.A., Yanagi Y., Watanabe T., Sato Y., Kimura H., Murata T. Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity. Microorganisms. 2019;7:705. doi: 10.3390/microorganisms7120705.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms7120705</ArticleId><ArticleId IdType="pmc">PMC6955869</ArticleId><ArticleId IdType="pubmed">31888254</ArticleId></ArticleIdList></Reference><Reference><Citation>Uddin M.K., Watanabe T., Arata M., Sato Y., Kimura H., Murata T. Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release. J. Virol. 2023;97:e00437-23. doi: 10.1128/jvi.00437-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00437-23</ArticleId><ArticleId IdType="pmc">PMC10308924</ArticleId><ArticleId IdType="pubmed">37195206</ArticleId></ArticleIdList></Reference><Reference><Citation>Balfour H.H., Sifakis F., Sliman J.A., Knight J.A., Schmeling D.O., Thomas W. Age-Specific Prevalence of Epstein–Barr Virus Infection Among Individuals Aged 6–19 Years in the United States and Factors Affecting Its Acquisition. J. Infect. Dis. 2013;208:1286–1293. doi: 10.1093/infdis/jit321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit321</ArticleId><ArticleId IdType="pubmed">23868878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifipour S., Davoodi Rad K. Seroprevalence of Epstein–Barr Virus among Children and Adults in Tehran, Iran. New Microbes New Infect. 2020;34:100641. doi: 10.1016/j.nmni.2019.100641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2019.100641</ArticleId><ArticleId IdType="pmc">PMC6997212</ArticleId><ArticleId IdType="pubmed">32025310</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z., Chen L., Zhong H., Cao L., Fu P., Xu J. Epidemiology and Clinical Characteristics of Epstein-Barr Virus Infection among Children in Shanghai, China, 2017–2022. Front Cell Infect. Microbiol. 2023;13:1139068. doi: 10.3389/fcimb.2023.1139068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1139068</ArticleId><ArticleId IdType="pmc">PMC10072160</ArticleId><ArticleId IdType="pubmed">37026057</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakhmola S., Jha H.C. Glial Cell Response to Epstein-Barr Virus Infection: A Plausible Contribution to Virus-Associated Inflammatory Reactions in the Brain. Virology. 2021;559:182–195. doi: 10.1016/j.virol.2021.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2021.04.005</ArticleId><ArticleId IdType="pubmed">33964684</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha H.C., Mehta D., Lu J., El-Naccache D., Shukla S.K., Kovacsics C., Kolson D., Robertson E.S. Gammaherpesvirus Infection of Human Neuronal Cells. mBio. 2015;6:10–1128. doi: 10.1128/mBio.01844-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01844-15</ArticleId><ArticleId IdType="pmc">PMC4669387</ArticleId><ArticleId IdType="pubmed">26628726</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson D.B., McDonnell W.J., Gonzalez-Ericsson P.I., Al-Rohil R.N., Mobley B.C., Salem J.-E., Wang D.Y., Sanchez V., Wang Y., Chastain C.A., et al. A Case Report of Clonal EBV-like Memory CD4+ T Cell Activation in Fatal Checkpoint Inhibitor-Induced Encephalitis. Nat. Med. 2019;25:1243–1250. doi: 10.1038/s41591-019-0523-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0523-2</ArticleId><ArticleId IdType="pmc">PMC6689251</ArticleId><ArticleId IdType="pubmed">31332390</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Ambrosio E., Khalighinejad F., Ionete C. Intravenous Immunoglobulins in an Adult Case of Post-EBV Cerebellitis. BMJ Case Rep. 2020;13:e231661. doi: 10.1136/bcr-2019-231661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-231661</ArticleId><ArticleId IdType="pmc">PMC7046430</ArticleId><ArticleId IdType="pubmed">32075812</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada T., Muraoka M., Yokoyama T., Toma T., Kanegane H., Yachie A. Cytokine Profiles in Children with Primary Epstein-Barr Virus Infection. Pediatr. Blood Cancer. 2013;60:E46–E48. doi: 10.1002/pbc.24480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.24480</ArticleId><ArticleId IdType="pubmed">23382108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui W.-Y., Bharti A., Wong N.-H.M., Jangra S., Botelho M.G., Yuen K.-S., Jin D.-Y. Suppression of CGAS- and RIG-I-Mediated Innate Immune Signaling by Epstein-Barr Virus Deubiquitinase BPLF1. PLoS Pathog. 2023;19:e1011186. doi: 10.1371/journal.ppat.1011186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011186</ArticleId><ArticleId IdType="pmc">PMC9983872</ArticleId><ArticleId IdType="pubmed">36802409</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooykaas M.J.G., van Gent M., Soppe J.A., Kruse E., Boer I.G.J., van Leenen D., Groot Koerkamp M.J.A., Holstege F.C.P., Ressing M.E., Wiertz E.J.H.J., et al. EBV MicroRNA BART16 Suppresses Type I IFN Signaling. J. Immunol. 2017;198:4062–4073. doi: 10.4049/jimmunol.1501605.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501605</ArticleId><ArticleId IdType="pubmed">28416598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullen M.M., Haan K.M., Longnecker R., Jardetzky T.S. Structure of the Epstein-Barr Virus Gp42 Protein Bound to the MHC Class II Receptor HLA-DR1. Mol. Cell. 2002;9:375–385. doi: 10.1016/S1097-2765(02)00465-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(02)00465-3</ArticleId><ArticleId IdType="pubmed">11864610</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor T.J. Herpes Simplex Virus. Front. Biosci. 2002;7:d752. doi: 10.2741/taylor.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/taylor</ArticleId><ArticleId IdType="pubmed">11861220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamperschroer C., Quinn D.G. The Role of Proinflammatory Cytokines in Wasting Disease During Lymphocytic Choriomeningitis Virus Infection. J. Immunol. 2002;169:340–349. doi: 10.4049/jimmunol.169.1.340.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.1.340</ArticleId><ArticleId IdType="pubmed">12077263</ArticleId></ArticleIdList></Reference><Reference><Citation>James C., Harfouche M., Welton N.J., Turner K.M., Abu-Raddad L.J., Gottlieb S.L., Looker K.J. Herpes Simplex Virus: Global Infection Prevalence and Incidence Estimates, 2016. Bull World Health Organ. 2020;98:315–329. doi: 10.2471/BLT.19.237149.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.19.237149</ArticleId><ArticleId IdType="pmc">PMC7265941</ArticleId><ArticleId IdType="pubmed">32514197</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige L., Zaeck L.M., Sehl-Ewert J., Finke S., Bourhy H. Innate Immune Signaling and Role of Glial Cells in Herpes Simplex Virus- and Rabies Virus-Induced Encephalitis. Viruses. 2021;13:2364. doi: 10.3390/v13122364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122364</ArticleId><ArticleId IdType="pmc">PMC8708193</ArticleId><ArticleId IdType="pubmed">34960633</ArticleId></ArticleIdList></Reference><Reference><Citation>Babaei A., Shatizadeh Malekshahi S., Pirbonyeh N., Moattari A. Prevalence and Clinical Manifestations of Herpes Simplex Virus Infection among Suspected Patients of Herpes Simplex Encephalitis in Shiraz, Iran. Virusdisease. 2021;32:266–271. doi: 10.1007/s13337-021-00680-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00680-9</ArticleId><ArticleId IdType="pmc">PMC8324718</ArticleId><ArticleId IdType="pubmed">34350317</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi R., Kim G., Jo I.J., Sim M.S., Song K.J., Kim B.J., Na D.L., Huh H.J., Kim J., Ki C., et al. Incidence and Clinical Features of Herpes Simplex Viruses (1 and 2) and Varicella-zoster Virus Infections in an Adult Korean Population with Aseptic Meningitis or Encephalitis. J. Med. Virol. 2014;86:957–962. doi: 10.1002/jmv.23920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23920</ArticleId><ArticleId IdType="pubmed">24610349</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao T.S., Fitzgerald K.A. The CGAS-STING Pathway for DNA Sensing. Mol. Cell. 2013;51:135–139. doi: 10.1016/j.molcel.2013.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.07.004</ArticleId><ArticleId IdType="pmc">PMC3782533</ArticleId><ArticleId IdType="pubmed">23870141</ArticleId></ArticleIdList></Reference><Reference><Citation>Unterholzner L. The Interferon Response to Intracellular DNA: Why so Many Receptors? Immunobiology. 2013;218:1312–1321. doi: 10.1016/j.imbio.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2013.07.007</ArticleId><ArticleId IdType="pubmed">23962476</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M.R., Kaminski J.J., Kurt-Jones E.A., Fitzgerald K.A. Pattern Recognition Receptors and the Innate Immune Response to Viral Infection. Viruses. 2011;3:920–940. doi: 10.3390/v3060920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3060920</ArticleId><ArticleId IdType="pmc">PMC3186011</ArticleId><ArticleId IdType="pubmed">21994762</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.B., Herbert J.J., Truong N.R., Cunningham A.L. Cytokines and Chemokines: The Vital Role They Play in Herpes Simplex Virus Mucosal Immunology. Front. Immunol. 2022;13:936235. doi: 10.3389/fimmu.2022.936235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.936235</ArticleId><ArticleId IdType="pmc">PMC9538770</ArticleId><ArticleId IdType="pubmed">36211447</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.P., Bowen G.N., Zhou S., Cerny A., Zacharia A., Knipe D.M., Finberg R.W., Kurt-Jones E.A. Role of Specific Innate Immune Responses in Herpes Simplex Virus Infection of the Central Nervous System. J. Virol. 2012;86:2273–2281. doi: 10.1128/JVI.06010-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06010-11</ArticleId><ArticleId IdType="pmc">PMC3302371</ArticleId><ArticleId IdType="pubmed">22171256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M.M., Knipe D.M., Finberg R.W. Herpes Simplex Virus 1 Interaction with Toll-like Receptor 2 Contributes to Lethal Encephalitis. Proc. Natl. Acad. Sci. USA. 2004;101:1315–1320. doi: 10.1073/pnas.0308057100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0308057100</ArticleId><ArticleId IdType="pmc">PMC337050</ArticleId><ArticleId IdType="pubmed">14739339</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravalli R.N., Hu S., Rowen T.N., Palmquist J.M., Lokensgard J.R. Cutting Edge: TLR2-Mediated Proinflammatory Cytokine and Chemokine Production by Microglial Cells in Response to Herpes Simplex Virus. J. Immunol. 2005;175:4189–4193. doi: 10.4049/jimmunol.175.7.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.7.4189</ArticleId><ArticleId IdType="pubmed">16177057</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao H., Chiu Y., Liang X., Xia S., Ayrapetyan M., Liu S., He C., Song R., Zeng J., Deng X., et al. Microglia Innate Immune Response Contributes to the Antiviral Defense and Blood–CSF Barrier Function in Human Choroid Plexus Organoids during HSV-1 Infection. J. Med. Virol. 2023;95:e28472. doi: 10.1002/jmv.28472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28472</ArticleId><ArticleId IdType="pmc">PMC10107173</ArticleId><ArticleId IdType="pubmed">36606611</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael B.D., Bricio-Moreno L., Sorensen E.W., Miyabe Y., Lian J., Solomon T., Kurt-Jones E.A., Luster A.D. Astrocyte- and Neuron-Derived CXCL1 Drives Neutrophil Transmigration and Blood-Brain Barrier Permeability in Viral Encephalitis. Cell Rep. 2020;32:108150. doi: 10.1016/j.celrep.2020.108150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108150</ArticleId><ArticleId IdType="pmc">PMC7548103</ArticleId><ArticleId IdType="pubmed">32937134</ArticleId></ArticleIdList></Reference><Reference><Citation>Poppers J., Mulvey M., Khoo D., Mohr I. Inhibition of PKR Activation by the Proline-Rich RNA Binding Domain of the Herpes Simplex Virus Type 1 Us11 Protein. J. Virol. 2000;74:11215–11221. doi: 10.1128/JVI.74.23.11215-11221.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.23.11215-11221.2000</ArticleId><ArticleId IdType="pmc">PMC113216</ArticleId><ArticleId IdType="pubmed">11070019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobeil P.A.M., Leib D.A. Herpes Simplex Virus Γ34.5 Interferes with Autophagosome Maturation and Antigen Presentation in Dendritic Cells. mBio. 2012;3:10-1128. doi: 10.1128/mBio.00267-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00267-12</ArticleId><ArticleId IdType="pmc">PMC3470650</ArticleId><ArticleId IdType="pubmed">23073763</ArticleId></ArticleIdList></Reference><Reference><Citation>Trgovcich J., Johnson D., Roizman B. Cell Surface Major Histocompatibility Complex Class II Proteins Are Regulated by the Products of the γ 1 34.5 and U L 41 Genes of Herpes Simplex Virus 1. J. Virol. 2002;76:6974–6986. doi: 10.1128/JVI.76.14.6974-6986.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.14.6974-6986.2002</ArticleId><ArticleId IdType="pmc">PMC136308</ArticleId><ArticleId IdType="pubmed">12072498</ArticleId></ArticleIdList></Reference><Reference><Citation>Riviere Y., Ahmed R., Southern P.J., Buchmeier M.J., Dutko F.J., Oldstone M.B. The S RNA Segment of Lymphocytic Choriomeningitis Virus Codes for the Nucleoprotein and Glycoproteins 1 and 2. J. Virol. 1985;53:966–968. doi: 10.1128/jvi.53.3.966-968.1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.53.3.966-968.1985</ArticleId><ArticleId IdType="pmc">PMC254733</ArticleId><ArticleId IdType="pubmed">3973970</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin B., Coutard B., Lelke M., Ferron F., Kerber R., Jamal S., Frangeul A., Baronti C., Charrel R., de Lamballerie X., et al. The N-Terminal Domain of the Arenavirus L Protein Is an RNA Endonuclease Essential in MRNA Transcription. PLoS Pathog. 2010;6:e1001038. doi: 10.1371/journal.ppat.1001038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001038</ArticleId><ArticleId IdType="pmc">PMC2940758</ArticleId><ArticleId IdType="pubmed">20862324</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M.K., Fuller-Pace F.V., Buchmeier M.J., Southern P.J. Analysis of the Genomic l Rna Segment from Lymphocytic Choriomeningitis Virus. Virology. 1987;161:448–456. doi: 10.1016/0042-6822(87)90138-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(87)90138-3</ArticleId><ArticleId IdType="pubmed">3318094</ArticleId></ArticleIdList></Reference><Reference><Citation>Charrel R.N., Coutard B., Baronti C., Canard B., Nougairede A., Frangeul A., Morin B., Jamal S., Schmidt C.L., Hilgenfeld R., et al. Arenaviruses and Hantaviruses: From Epidemiology and Genomics to Antivirals. Antivir. Res. 2011;90:102–114. doi: 10.1016/j.antiviral.2011.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.02.009</ArticleId><ArticleId IdType="pubmed">21356244</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvato M.S., Shimomaye E.M. The Completed Sequence of Lymphocytic Choriomeningitis Virus Reveals a Unique RNA Structure and a Gene for a Zinc Finger Protein. Virology. 1989;173:1–10. doi: 10.1016/0042-6822(89)90216-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(89)90216-X</ArticleId><ArticleId IdType="pubmed">2510401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Riaño E., Cheng B.Y.H., de la Torre J.C., Martínez-Sobrido L. The C-Terminal Region of Lymphocytic Choriomeningitis Virus Nucleoprotein Contains Distinct and Segregable Functional Domains Involved in NP-Z Interaction and Counteraction of the Type I Interferon Response. J. Virol. 2011;85:13038–13048. doi: 10.1128/JVI.05834-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05834-11</ArticleId><ArticleId IdType="pmc">PMC3233175</ArticleId><ArticleId IdType="pubmed">21976642</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez-Sobrido L., Zúñiga E.I., Rosario D., García-Sastre A., de la Torre J.C. Inhibition of the Type I Interferon Response by the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus. J. Virol. 2006;80:9192–9199. doi: 10.1128/JVI.00555-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00555-06</ArticleId><ArticleId IdType="pmc">PMC1563941</ArticleId><ArticleId IdType="pubmed">16940530</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinschewer D.D., Perez M., de la Torre J.C. Role of the Virus Nucleoprotein in the Regulation of Lymphocytic Choriomeningitis Virus Transcription and RNA Replication. J. Virol. 2003;77:3882–3887. doi: 10.1128/JVI.77.6.3882-3887.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.6.3882-3887.2003</ArticleId><ArticleId IdType="pmc">PMC149515</ArticleId><ArticleId IdType="pubmed">12610166</ArticleId></ArticleIdList></Reference><Reference><Citation>Labudova M., Tomaskova J., Skultety L., Pastorek J., Pastorekova S. The Nucleoprotein of Lymphocytic Choriomeningitis Virus Facilitates Spread of Persistent Infection through Stabilization of the Keratin Network. J. Virol. 2009;83:7842–7849. doi: 10.1128/JVI.00309-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00309-09</ArticleId><ArticleId IdType="pmc">PMC2715769</ArticleId><ArticleId IdType="pubmed">19494018</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume M., Takashima A., Iwasaki M. A Small Stem-Loop-Forming Region within the 3′-UTR of a Nonpolyadenylated LCMV MRNA Promotes Translation. J. Biol. Chem. 2022;298:101576. doi: 10.1016/j.jbc.2022.101576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101576</ArticleId><ArticleId IdType="pmc">PMC8888456</ArticleId><ArticleId IdType="pubmed">35026225</ArticleId></ArticleIdList></Reference><Reference><Citation>Igonet S., Vaney M.-C., Vonrhein C., Bricogne G., Stura E.A., Hengartner H., Eschli B., Rey F.A. X-Ray Structure of the Arenavirus Glycoprotein GP2 in Its Postfusion Hairpin Conformation. Proc. Natl. Acad. Sci. USA. 2011;108:19967–19972. doi: 10.1073/pnas.1108910108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1108910108</ArticleId><ArticleId IdType="pmc">PMC3250147</ArticleId><ArticleId IdType="pubmed">22123988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan B.M., Emonet S.F., Welch M.J., Lee A.M., Campbell K.P., de la Torre J.C., Oldstone M.B. Point Mutation in the Glycoprotein of Lymphocytic Choriomeningitis Virus Is Necessary for Receptor Binding, Dendritic Cell Infection, and Long-Term Persistence. Proc. Natl. Acad. Sci. USA. 2011;108:2969–2974. doi: 10.1073/pnas.1019304108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1019304108</ArticleId><ArticleId IdType="pmc">PMC3041138</ArticleId><ArticleId IdType="pubmed">21270335</ArticleId></ArticleIdList></Reference><Reference><Citation>Dykewicz C.A. Lymphocytic Choriomeningitis Outbreak Associated With Nude Mice in a Research Institute. JAMA J. Am. Med. Assoc. 1992;267:1349. doi: 10.1001/jama.1992.03480100055030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1992.03480100055030</ArticleId><ArticleId IdType="pubmed">1740856</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilibic-Cavlek T., Savic V., Ferenc T., Mrzljak A., Barbic L., Bogdanic M., Stevanovic V., Tabain I., Ferencak I., Zidovec-Lepej S. Lymphocytic Choriomeningitis—Emerging Trends of a Neglected Virus: A Narrative Review. Trop. Med. Infect. Dis. 2021;6:88. doi: 10.3390/tropicalmed6020088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed6020088</ArticleId><ArticleId IdType="pmc">PMC8163193</ArticleId><ArticleId IdType="pubmed">34070581</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonthius D.J., Mahoney J., Buchmeier M.J., Karacay B., Taggard D. Critical Role for Glial Cells in the Propagation and Spread of Lymphocytic Choriomeningitis Virus in the Developing Rat Brain. J. Virol. 2002;76:6618–6635. doi: 10.1128/JVI.76.13.6618-6635.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.13.6618-6635.2002</ArticleId><ArticleId IdType="pmc">PMC136288</ArticleId><ArticleId IdType="pubmed">12050375</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox J.G., Otto G., Colby L.A. Laboratory Animal Medicine. Elsevier; Amsterdam, The Netherlands: 2015. Selected Zoonoses; pp. 1313–1370.</Citation></Reference><Reference><Citation>Puccini J.M., Ruller C.M., Robinson S.M., Knopp K.A., Buchmeier M.J., Doran K.S., Feuer R. Distinct Neural Stem Cell Tropism, Early Immune Activation, and Choroid Plexus Pathology Following Coxsackievirus Infection in the Neonatal Central Nervous System. Lab. Investig. 2014;94:161–181. doi: 10.1038/labinvest.2013.138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2013.138</ArticleId><ArticleId IdType="pubmed">24378643</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonthius D.J. Lymphocytic Choriomeningitis Virus: An Underrecognized Cause of Neurologic Disease in the Fetus, Child, and Adult. Semin. Pediatr. Neurol. 2012;19:89–95. doi: 10.1016/j.spen.2012.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spen.2012.02.002</ArticleId><ArticleId IdType="pmc">PMC4256959</ArticleId><ArticleId IdType="pubmed">22889536</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce B.D., Po C.L., Pisell T.L., Miller A.H. Lymphocytic Responses and the Gradual Hippocampal Neuron Loss Following Infection with Lymphocytic Choriomeningitis Virus (LCMV) J. Neuroimmunol. 1999;101:137–147. doi: 10.1016/S0165-5728(99)00128-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(99)00128-9</ArticleId><ArticleId IdType="pubmed">10580797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Kurt-Jones E.A., Mandell L., Cerny A., Chan M., Golenbock D.T., Finberg R.W. MyD88 Is Critical for the Development of Innate and Adaptive Immunity during Acute Lymphocytic Choriomeningitis Virus Infection. Eur. J. Immunol. 2005;35:822–830. doi: 10.1002/eji.200425730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200425730</ArticleId><ArticleId IdType="pubmed">15724245</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratumchai I., Zak J., Huang Z., Min B., Oldstone M.B.A., Teijaro J.R. B Cell–Derived IL-27 Promotes Control of Persistent LCMV Infection. Proc. Natl. Acad. Sci. USA. 2022;119:e2116741119. doi: 10.1073/pnas.2116741119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2116741119</ArticleId><ArticleId IdType="pmc">PMC8784116</ArticleId><ArticleId IdType="pubmed">35022243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin A.A., Wojciechowski S.E., Hildeman D.A. Androgens Suppress Antigen-Specific T Cell Responses and IFN-γ Production during Intracranial LCMV Infection. J. Neuroimmunol. 2010;226:8–19. doi: 10.1016/j.jneuroim.2010.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.05.026</ArticleId><ArticleId IdType="pmc">PMC4222683</ArticleId><ArticleId IdType="pubmed">20619904</ArticleId></ArticleIdList></Reference><Reference><Citation>Che Mat N.F., Siddiqui S., Mehta D., Seaver K., Banete A., Alothaimeen T., Gee K., Basta S. Lymphocytic Choriomeningitis Virus Infection of Dendritic Cells Interferes with TLR-Induced IL-12/IL-23 Cytokine Production in an IL-10 Independent Manner. Cytokine. 2018;108:105–114. doi: 10.1016/j.cyto.2018.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.03.017</ArticleId><ArticleId IdType="pubmed">29602153</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Halle A., Kurt-Jones E.A., Cerny A.M., Porpiglia E., Rogers M., Golenbock D.T., Finberg R.W. Lymphocytic Choriomeningitis Virus (LCMV) Infection of CNS Glial Cells Results in TLR2-MyD88/Mal-Dependent Inflammatory Responses. J. Neuroimmunol. 2008;194:70–82. doi: 10.1016/j.jneuroim.2007.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.11.018</ArticleId><ArticleId IdType="pmc">PMC2291360</ArticleId><ArticleId IdType="pubmed">18295350</ArticleId></ArticleIdList></Reference><Reference><Citation>Khailany R.A., Safdar M., Ozaslan M. Genomic Characterization of a Novel SARS-CoV-2. Gene Rep. 2020;19:100682. doi: 10.1016/j.genrep.2020.100682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2020.100682</ArticleId><ArticleId IdType="pmc">PMC7161481</ArticleId><ArticleId IdType="pubmed">32300673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardenbrook N.J., Zhang P. A Structural View of the SARS-CoV-2 Virus and Its Assembly. Curr. Opin. Virol. 2022;52:123–134. doi: 10.1016/j.coviro.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8642146</ArticleId><ArticleId IdType="pubmed">34915287</ArticleId></ArticleIdList></Reference><Reference><Citation>Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.-L., Lavillette D., Denolly S. The SARS-CoV-2 Envelope and Membrane Proteins Modulate Maturation and Retention of the Spike Protein, Allowing Assembly of Virus-like Particles. J. Biol. Chem. 2021;296:100111. doi: 10.1074/jbc.RA120.016175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.016175</ArticleId><ArticleId IdType="pmc">PMC7833635</ArticleId><ArticleId IdType="pubmed">33229438</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Nomura N., Muramoto Y., Ekimoto T., Uemura T., Liu K., Yui M., Kono N., Aoki J., Ikeguchi M., et al. Structure of SARS-CoV-2 Membrane Protein Essential for Virus Assembly. Nat. Commun. 2022;13:4399. doi: 10.1038/s41467-022-32019-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32019-3</ArticleId><ArticleId IdType="pmc">PMC9355944</ArticleId><ArticleId IdType="pubmed">35931673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaffagni M., Harris J.M., Patop I.L., Pamudurti N.R., Nguyen S., Kadener S. SARS-CoV-2 Nsp14 Mediates the Effects of Viral Infection on the Host Cell Transcriptome. Elife. 2022;11:e71945. doi: 10.7554/eLife.71945.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.71945</ArticleId><ArticleId IdType="pmc">PMC9054133</ArticleId><ArticleId IdType="pubmed">35293857</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeletti S., Benvenuto D., Bianchi M., Giovanetti M., Pascarella S., Ciccozzi M. COVID-2019: The Role of the Nsp2 and Nsp3 in Its Pathogenesis. J. Med. Virol. 2020;92:584–588. doi: 10.1002/jmv.25719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25719</ArticleId><ArticleId IdType="pmc">PMC7228367</ArticleId><ArticleId IdType="pubmed">32083328</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno Y., Kimura I., Uriu K., Fukushi M., Irie T., Koyanagi Y., Sauter D., Gifford R.J., Nakagawa S., Sato K. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant. Cell Rep. 2020;32:108185. doi: 10.1016/j.celrep.2020.108185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108185</ArticleId><ArticleId IdType="pmc">PMC7473339</ArticleId><ArticleId IdType="pubmed">32941788</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto Y., Itoh Y., Suzuki T., Tanaka T., Sakai Y., Koido M., Hata C., Wang C.-X., Otani M., Moriishi K., et al. SARS-CoV-2 ORF6 Disrupts Nucleocytoplasmic Trafficking to Advance Viral Replication. Commun. Biol. 2022;5:483. doi: 10.1038/s42003-022-03427-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03427-4</ArticleId><ArticleId IdType="pmc">PMC9120032</ArticleId><ArticleId IdType="pubmed">35590097</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R., Zhao Q., Rao J., Zeng F., Yuan S., Ji M., Sun X., Li J., Yang J., Cui J., et al. SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-α-Induced Apoptosis in Cells. Front. Microbiol. 2021;12:654709. doi: 10.3389/fmicb.2021.654709.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.654709</ArticleId><ArticleId IdType="pmc">PMC8414645</ArticleId><ArticleId IdType="pubmed">34484133</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., Zhuang M., Deng J., Zheng Y., Zhang J., Nan M., Zhang X., Gao C., Wang P. SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of the RIG-I/MDA-5–MAVS, TLR3–TRIF, and CGAS–STING Signaling Pathways. J. Med. Virol. 2021;93:5376–5389. doi: 10.1002/jmv.27050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena G.E., Martinez P.P., Mahmud A.S., Marquet P.A., Buckee C.O., Santillana M. Socioeconomic Status Determines COVID-19 Incidence and Related Mortality in Santiago, Chile. Science. 2021;372:eabg5298. doi: 10.1126/science.abg5298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg5298</ArticleId><ArticleId IdType="pmc">PMC8158961</ArticleId><ArticleId IdType="pubmed">33906968</ArticleId></ArticleIdList></Reference><Reference><Citation>Balloff C., Bandlow C., Bernhard M., Brandenburger T., Bludau P., Elben S., Feldt T., Hartmann C.J., Heinen E., Ingwersen J., et al. Prevalence and Prognostic Value of Neurological Affections in Hospitalized Patients with Moderate to Severe COVID-19 Based on Objective Assessments. Sci. Rep. 2023;13:19619. doi: 10.1038/s41598-023-46124-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-46124-w</ArticleId><ArticleId IdType="pmc">PMC10638293</ArticleId><ArticleId IdType="pubmed">37949882</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Silva L.S., Nogueira M.H., Antunes A.S.L.M., Vendramini P.H., Valença A.G.F., Brandão-Teles C., Zuccoli G.d.S., et al. Morphological, Cellular, and Molecular Basis of Brain Infection in COVID-19 Patients. Proc. Natl. Acad. Sci. USA. 2022;119:e2200960119. doi: 10.1073/pnas.2200960119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez-Mármol R., Giordano-Santini R., Kaulich E., Cho A.-N., Przybyla M., Riyadh M.A., Robinson E., Chew K.Y., Amor R., Meunier F.A., et al. SARS-CoV-2 Infection and Viral Fusogens Cause Neuronal and Glial Fusion That Compromises Neuronal Activity. Sci. Adv. 2023;9:eadg2248. doi: 10.1126/sciadv.adg2248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adg2248</ArticleId><ArticleId IdType="pmc">PMC10246911</ArticleId><ArticleId IdType="pubmed">37285437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Gebo K.A., Abraham A.G., Habtehyimer F., Patel E.U., Laeyendecker O., Gniadek T.J., Fernandez R.E., Baker O.R., Ram M., et al. Dynamics of Inflammatory Responses after SARS-CoV-2 Infection by Vaccination Status in the USA: A Prospective Cohort Study. Lancet Microbe. 2023;4:e692–e703. doi: 10.1016/S2666-5247(23)00171-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00171-4</ArticleId><ArticleId IdType="pmc">PMC10475695</ArticleId><ArticleId IdType="pubmed">37659419</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereson M.J., Badano M.N., Aloisi N., Chuit R.E., de Bracco M.M., Bare P. TNF-α Levels in Respiratory Samples Are Associated with SARS-CoV-2 Infection. Microbiol. Spectr. 2022;10:e01411-21. doi: 10.1128/spectrum.01411-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01411-21</ArticleId><ArticleId IdType="pmc">PMC8826736</ArticleId><ArticleId IdType="pubmed">35138148</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeldt C.J., Cerikan B., Cortese M., Frankish J., Lee J.-Y., Plociennikowska A., Heigwer F., Prasad V., Joecks S., Burkart S.S., et al. SARS-CoV-2 Infection Induces a pro-Inflammatory Cytokine Response through CGAS-STING and NF-ΚB. Commun. Biol. 2022;5:45. doi: 10.1038/s42003-021-02983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02983-5</ArticleId><ArticleId IdType="pmc">PMC8755718</ArticleId><ArticleId IdType="pubmed">35022513</ArticleId></ArticleIdList></Reference><Reference><Citation>Planès R., Bert J.-B., Tairi S., BenMohamed L., Bahraoui E. SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions. Viruses. 2022;14:999. doi: 10.3390/v14050999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14050999</ArticleId><ArticleId IdType="pmc">PMC9146335</ArticleId><ArticleId IdType="pubmed">35632741</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Pollard K.M., Campbell A.W. Environmental Triggers and Autoimmunity. Autoimmune Dis. 2014;2014:1–2. doi: 10.1155/2014/798029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/798029</ArticleId><ArticleId IdType="pmc">PMC4290643</ArticleId><ArticleId IdType="pubmed">25610638</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaresan B., Shirafkan F., Ripperger K., Rattay K. The Role of Viral Infections in the Onset of Autoimmune Diseases. Viruses. 2023;15:782. doi: 10.3390/v15030782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030782</ArticleId><ArticleId IdType="pmc">PMC10051805</ArticleId><ArticleId IdType="pubmed">36992490</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K., Cortese M., Healy B.C., Kuhle J., Mina M.J., Leng Y., Elledge S.J., Niebuhr D.W., Scher A.I., Munger K.L., et al. Longitudinal Analysis Reveals High Prevalence of Epstein-Barr Virus Associated with Multiple Sclerosis. Science. 2022;375:296–301. doi: 10.1126/science.abj8222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj8222</ArticleId><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirohata S., Sakuma Y., Yanagida T., Yoshio T. Association of Cerebrospinal Fluid Anti-Sm Antibodies with Acute Confusional State in Systemic Lupus Erythematosus. Arthritis Res. Ther. 2014;16:450. doi: 10.1186/s13075-014-0450-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-014-0450-z</ArticleId><ArticleId IdType="pmc">PMC4203882</ArticleId><ArticleId IdType="pubmed">25273532</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Tu Z., Zhang X., Du K., Xie Z., Lin Z. Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus: A Review. Front. Cell Dev. Biol. 2022;10:998328. doi: 10.3389/fcell.2022.998328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.998328</ArticleId><ArticleId IdType="pmc">PMC9484581</ArticleId><ArticleId IdType="pubmed">36133921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson C.S., Stocks B.T., Hoopes E.M., Rhoads J.P., McNew K.L., Major A.S., Moore D.J. Metabolic Preconditioning in CD4+ T Cells Restores Inducible Immune Tolerance in Lupus-Prone Mice. JCI Insight. 2021;6:e143245. doi: 10.1172/jci.insight.143245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143245</ArticleId><ArticleId IdType="pmc">PMC8525586</ArticleId><ArticleId IdType="pubmed">34403367</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobi A.M., Zhang J., Mackay M., Aranow C., Diamond B. Phenotypic Characterization of Autoreactive B Cells—Checkpoints of B Cell Tolerance in Patients with Systemic Lupus Erythematosus. PLoS ONE. 2009;4:e5776. doi: 10.1371/journal.pone.0005776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005776</ArticleId><ArticleId IdType="pmc">PMC2685013</ArticleId><ArticleId IdType="pubmed">19488401</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihaylova N., Chipinski P., Bradyanova S., Velikova T., Ivanova-Todorova E., Chausheva S., Herbáth M., Kalinova D., Prechl J., Kyurkchiev D., et al. Suppression of Autoreactive T and B Lymphocytes by Anti-Annexin A1 Antibody in a Humanized NSG Murine Model of Systemic Lupus Erythematosus. Clin. Exp. Immunol. 2020;199:278–293. doi: 10.1111/cei.13399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13399</ArticleId><ArticleId IdType="pmc">PMC7008224</ArticleId><ArticleId IdType="pubmed">31724735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J., Su S., You T., Xia T., Lin X., Chen Z., Zhang L. Serum Interleukin-6 Level Is Correlated with the Disease Activity of Systemic Lupus Erythematosus: A Meta-Analysis. Clinics. 2020;75:e1801. doi: 10.6061/clinics/2020/e1801.</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2020/e1801</ArticleId><ArticleId IdType="pmc">PMC7536892</ArticleId><ArticleId IdType="pubmed">33084768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafat S., Mohamed Y.Y., Ahmed M.E., Abdelaleem E.A. Interleukin-23 Serum Level in Systemic Lupus Erythematosus Patients: Relation to Disease Activity and Different Disease Parameters. Egypt. Rheumatol. 2022;44:139–143. doi: 10.1016/j.ejr.2021.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejr.2021.10.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi D., Elefante E., Schilirò D., Signorini V., Trentin F., Bortoluzzi A., Tani C. One Year in Review 2022: Systemic Lupus Erythematosus. Clin. Exp. Rheumatol. 2022;40:4–14. doi: 10.55563/clinexprheumatol/nolysy.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/nolysy</ArticleId><ArticleId IdType="pubmed">35088691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Bunting K.A., Kalsi J., Hinks J.A., Latchman D.S., Pearl L.H., Isenberg D.A. Lupus Autoantibodies to Native DNA Preferentially Bind DNA Presented on PolIV. Immunology. 2005;114:418–427. doi: 10.1111/j.1365-2567.2005.02090.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2005.02090.x</ArticleId><ArticleId IdType="pmc">PMC1782086</ArticleId><ArticleId IdType="pubmed">15720443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohl K., Tenbrock K. Inflammatory Cytokines in Systemic Lupus Erythematosus. J. Biomed. Biotechnol. 2011;2011:432595. doi: 10.1155/2011/432595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/432595</ArticleId><ArticleId IdType="pmc">PMC3196871</ArticleId><ArticleId IdType="pubmed">22028588</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber M.R.W., Falasinnu T., Ramsey-Goldman R., Clarke A.E. The Global Epidemiology of SLE: Narrowing the Knowledge Gaps. Rheumatology. 2023;62:i4–i9. doi: 10.1093/rheumatology/keac610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac610</ArticleId><ArticleId IdType="pmc">PMC10050933</ArticleId><ArticleId IdType="pubmed">36987602</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G., Ye S., Xie S., Ye L., Lin C., Yang M., Shi X., Wang F., Li B., Li M., et al. The Cytomegalovirus Protein US31 Induces Inflammation through Mono-Macrophages in Systemic Lupus Erythematosus by Promoting NF-ΚB2 Activation. Cell Death Dis. 2018;9:104. doi: 10.1038/s41419-017-0122-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0122-4</ArticleId><ArticleId IdType="pmc">PMC5833803</ArticleId><ArticleId IdType="pubmed">29367719</ArticleId></ArticleIdList></Reference><Reference><Citation>Neo J.Y.J., Wee S.Y.K., Bonne I., Tay S.H., Raida M., Jovanovic V., Fairhurst A.-M., Lu J., Hanson B.J., MacAry P.A. Characterisation of a Human Antibody That Potentially Links Cytomegalovirus Infection with Systemic Lupus Erythematosus. Sci. Rep. 2019;9:9998. doi: 10.1038/s41598-019-46329-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46329-y</ArticleId><ArticleId IdType="pmc">PMC6620320</ArticleId><ArticleId IdType="pubmed">31292492</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh A.-H., Jhou Y.-J., Liang C.-T., Chang M., Wang S.-L. Fragment of Tegument Protein Pp65 of Human Cytomegalovirus Induces Autoantibodies in BALB/c Mice. Arthritis Res. Ther. 2011;13:R162. doi: 10.1186/ar3481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3481</ArticleId><ArticleId IdType="pmc">PMC3308095</ArticleId><ArticleId IdType="pubmed">21989080</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard M.L., Gilkeson G. Mouse Models of Lupus: What They Tell Us and What They Don’t. Lupus Sci. Med. 2018;5:e000199. doi: 10.1136/lupus-2016-000199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2016-000199</ArticleId><ArticleId IdType="pmc">PMC5786947</ArticleId><ArticleId IdType="pubmed">29387435</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon U., Park S., Oh S., Kim W.-U., Park S.-H., Lee S.-H., Cho C.-S., Kim H.-Y., Lee W.-K., Lee S. Patients with Systemic Lupus Erythematosus Have Abnormally Elevated Epstein–Barr Virus Load in Blood. Arthritis Res. Ther. 2004;6:R295. doi: 10.1186/ar1181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar1181</ArticleId><ArticleId IdType="pmc">PMC464871</ArticleId><ArticleId IdType="pubmed">15225364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Nicholas M.W., Conway K.L., Sen P., Diz R., Tisch R.M., Clarke S.H. EBV Latent Membrane Protein 2A Induces Autoreactive B Cell Activation and TLR Hypersensitivity. J. Immunol. 2006;177:2793–2802. doi: 10.4049/jimmunol.177.5.2793.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.5.2793</ArticleId><ArticleId IdType="pubmed">16920914</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D., Oudit O., Hajtovic S., Sarbaugh D., Salis R., Adebowale T., James J., Spatz L.A. Antibodies to an Epstein Barr Virus Protein That Cross-React with DsDNA Have Pathogenic Potential. Mol. Immunol. 2021;132:41–52. doi: 10.1016/j.molimm.2021.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.01.013</ArticleId><ArticleId IdType="pubmed">33545624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Quintial R., Nguyen A., Kono D.H., Oldstone M.B.A., Theofilopoulos A.N., Baccala R. Lupus Acceleration by a MAVS-Activating RNA Virus Requires Endosomal TLR Signaling and Host Genetic Predisposition. PLoS ONE. 2018;13:e0203118. doi: 10.1371/journal.pone.0203118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0203118</ArticleId><ArticleId IdType="pmc">PMC6130858</ArticleId><ArticleId IdType="pubmed">30199535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly J.G., Urowitz M.B., Su L., Bae S.C., Gordon C., Wallace D.J., Clarke A., Bernatsky S., Isenberg D., Rahman A., et al. Prospective Analysis of Neuropsychiatric Events in an International Disease Inception Cohort of Patients with Systemic Lupus Erythematosus. Ann. Rheum. Dis. 2010;69:529–535. doi: 10.1136/ard.2008.106351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2008.106351</ArticleId><ArticleId IdType="pmc">PMC2929162</ArticleId><ArticleId IdType="pubmed">19359262</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang M.H., Corzillius M., Bae S.C., Lew R.A., Fortin P.R., Gordon C., Isenberg D., Alarcón G.S., Straaton K.V., Denburg J., et al. The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Lupus Syndromes. Arthritis Rheum. 1999;42:599–608. doi: 10.1002/1529-0131(199904)42:4&lt;599::AID-ANR2&gt;3.0.CO;2-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199904)42:4&lt;599::AID-ANR2&gt;3.0.CO;2-F</ArticleId><ArticleId IdType="pubmed">10211873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sled J.G., Spring S., van Eede M., Lerch J.P., Ullal S., Sakic B. Time Course and Nature of Brain Atrophy in the MRL Mouse Model of Central Nervous System Lupus. Arthritis Rheum. 2009;60:1764–1774. doi: 10.1002/art.24523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24523</ArticleId><ArticleId IdType="pubmed">19479832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Foster J., Sakic B. Distribution and Prevalence of Leukocyte Phenotypes in Brains of Lupus-Prone Mice. J. Neuroimmunol. 2006;179:26–36. doi: 10.1016/j.jneuroim.2006.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2006.06.023</ArticleId><ArticleId IdType="pubmed">16904195</ArticleId></ArticleIdList></Reference><Reference><Citation>ElMelegy T.T.H., Radwan A.H., Herdan O.M., Rashed H.G. Does Herpes Simplex Virus Have a Role in the Pathogenesis of Systemic Lupus Erythematosus in Egyptians? Egypt. J. Immunol. 2022;29:48–56. doi: 10.55133/eji.290206.</Citation><ArticleIdList><ArticleId IdType="doi">10.55133/eji.290206</ArticleId><ArticleId IdType="pubmed">35436054</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang M., Liu M., Chen M., Li N., Zhao Y., Zhang S., He P., Yu Q. Mendelian Randomization Analysis Suggests No Associations of Herpes Simplex Virus Infections with Systemic Lupus Erythematosus. J. Med. Virol. 2023;95:e28649. doi: 10.1002/jmv.28649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28649</ArticleId><ArticleId IdType="pubmed">36897027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajon A.E., Dickson L.M., Fisher B.T., Hodinka R.L. Fatal Disseminated Adenovirus Infection in a Young Adult with Systemic Lupus Erythematosus. J. Clin. Virol. 2011;50:80–83. doi: 10.1016/j.jcv.2010.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.09.021</ArticleId><ArticleId IdType="pubmed">21074489</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrasson J., De Haes P., De Langhe E. Systemic Lupus Erythematosus Mimicry Caused by Viral Infection with Coxsackie B4. Rheumatology. 2021;60:e203–e204. doi: 10.1093/rheumatology/keaa852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa852</ArticleId><ArticleId IdType="pubmed">33320244</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlejewski K., Bukowska-Ośko I., Rydzanicz M., Pawełczyk A., Caraballo Cortès K., Osuch S., Paciorek M., Dzieciątkowski T., Radkowski M., Laskus T. Next-Generation Sequencing in the Diagnosis of Viral Encephalitis: Sensitivity and Clinical Limitations. Sci. Rep. 2020;10:16173. doi: 10.1038/s41598-020-73156-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73156-3</ArticleId><ArticleId IdType="pmc">PMC7528011</ArticleId><ArticleId IdType="pubmed">32999423</ArticleId></ArticleIdList></Reference><Reference><Citation>Suomalainen M., Greber U.F. Virus Infection Variability by Single-Cell Profiling. Viruses. 2021;13:1568. doi: 10.3390/v13081568.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081568</ArticleId><ArticleId IdType="pmc">PMC8402812</ArticleId><ArticleId IdType="pubmed">34452433</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren M., Zhou Y., Tu T., Jiang D., Pang M., Li Y., Luo Y., Yao X., Yang Z., Wang Y. RVG Peptide-Functionalized Favipiravir Nanoparticle Delivery System Facilitates Antiviral Therapy of Neurotropic Virus Infection in a Mouse Model. Int. J. Mol. Sci. 2023;24:5851. doi: 10.3390/ijms24065851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065851</ArticleId><ArticleId IdType="pmc">PMC10058582</ArticleId><ArticleId IdType="pubmed">36982925</ArticleId></ArticleIdList></Reference><Reference><Citation>Surnar B., Shah A.S., Park M., Kalathil A.A., Kamran M.Z., Ramirez Jaime R., Toborek M., Nair M., Kolishetti N., Dhar S. Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress. ACS Nano. 2021;15:15741–15753. doi: 10.1021/acsnano.0c09553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.0c09553</ArticleId><ArticleId IdType="pmc">PMC10134441</ArticleId><ArticleId IdType="pubmed">34355558</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain M., Duggal S., Chugh T. Das Cytomegalovirus Infection in Non-Immunosuppressed Critically Ill Patients. J. Infect. Dev. Ctries. 2011;5:571–579. doi: 10.3855/jidc.1487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.1487</ArticleId><ArticleId IdType="pubmed">21841300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>